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ABSTRACT 
 
TOTAL ORGANIC IODINE QUANTIFICATION AND OCCURRENCE IN 
DRINKING WATER, AND TOXICTY ASSESSMENT OF IODINATED 
DISINFECTION BY-PRODUCTS 
 
FEBRUARY 2017 
RASSIL SAYESS, B.S., AMERICAN UNIVERSITY OF BEIRUT 
M.S., AMERICAN UNIVERSITY OF BEIRUT 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor David A. Reckhow 
 
 The focus of this work has been placed is on iodinated DBPs (I-DBPs), measured 
using total organic iodine (TOI), a surrogate measure of iodinated organics. This is due to 
the growing toxicity literature that places I-DBPs among the most toxic of all DBPs. To 
measure TOI in water, a new method was developed. This method combines adsorption, 
combustion, and trapping of combustion products, with an offline inductively coupled 
plasma/mass spectrometer (ICP-MS) for iodide detection. Three factors were varied 
across two levels each in order to optimize the method. The chosen method used a sample 
pH of less than 1 prior to adsorption, a solution of 2% tetramethyl ammonium hydroxide 
(TMAH) in the trap solution, and a TMAH wash solution for the ICP-MS.  
 The method was then used to quantify TOI in raw and treated waters in three 
water treatment plants in the Northeast US over a period of fifteen months across 
different treatment plants and in different locations within the same systems. The results 
showed that there was substantial inter-monthly variability in TOI where values cluster 
high or low for months at a time. There was no change in TOI concentration upon 
treatment, suggesting that the TOI components may have shifted between the raw and 
treated waters. The results of a multivariate regression showed that dissolved organic 
carbon, specific UV254 absorbance, combined residual chlorine, and pH were all 
correlated with TOI concentration. These parameters were then used to fit a predictive 
model for TOI formation in water.  
 Expanding on the current literature on the toxicological profile of I-DBPs, the 
impact of six I-DBPs on healthy human colon epithelial cells, CCD 841 CoN, was tested. 
The rank order for cytotoxicity of the I-DBPs was found to be iodoacetic acid 
>iodoacetamide >bromoiodoacetamide >chloroiodoacetamide> bromoiodoacetic acid ≈ 
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diiodoacetic acid. Iodoacetamide was 3.5 times more cytotoxic than 
bromoiodoacetamide, which in turn was 2.7 times more cytotoxic than 
chloroiodoacetamide. For both dihaloacids, the cytotoxicity was less than 1% of that of 
the monohaloacid. Apart from iodoacetic acid, the nitrogenous I-DBPs evaluated in this 
study proved to be more cytotoxic than the carbonaceous I-DBPs. 
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CHAPTER 1 
 
OVERVIEW AND INTRODUCTION 
 
 Chlorination of drinking water is considered one of the most important 
advancements in public health in the twentieth century, having led to a substantial 
decrease in water-borne diseases in the United States (CDC, 1999). Microorganisms are 
effectively inactivated in drinking water through the use of powerful oxidants such as 
chlorine, chlorine dioxide, and chloramines. The non-selective nature of these chemicals 
also leads to the oxidation of natural organic matter (NOM) and bromide/iodide that are 
naturally present in source waters, and further yields halogenated disinfection by-
products (DBPs). In 1974, trihalomethanes were the first DBPs identified in chlorinated 
waters (Rook, 1974). Four decades later, more than 600 DBPs have been identified in the 
literature (Richardson et al., 2008). The parameter total organic halogen (TOX) has been 
used as a surrogate measure of the sum of all DBPs in a water sample (Li et al., 2002; 
Reckhow et al., 1990; Richardson, 2003). Despite the hundreds of DBPs that have been 
identified so far, 50% of the individual compounds that make up TOX in chlorinated 
waters remain unidentified, while the percentage is even higher in chloraminated waters 
(Christman et al., 1983; Diehl et al., 2000; Hua and Reckhow, 2006; Kanniganti et al., 
1992; Krasner et al., 1989; Miller et al., 1983; Reckhow and Singer, 1984; Richardson, 
2003).  
 Epidemiological studies have reported a positive association between exposure to 
DBPs (particularly trihalomethanes) in chlorinated drinking water to an increased risk of 
bladder, colon, and rectum cancers (Bove et al., 2007; Bull et al. 1995; Cantor et al., 
2010; Costet et al., 2011; King and Marrett, 1996; King et al., 2000; Koivusalo et al., 
  2 
1997; McGeehin et al., 1993; Morris et al., 1992; Rahman et al., 2010; Villanueva et al., 
2004; Villanueva et al., 2007). This raised an important public health issue and led to the 
regulation of eleven DBPs under the Stage 1 and Stage 2 Disinfectant/Disinfection 
Byproduct (D/DBP) Rules (United States Environmental Protection Agency (USEPA), 
1999; 2003). The use of chloramine as a final disinfectant leads to a lower formation of 
regulated DBPs (Krasner et al., 1989; Zhang et al., 2000). This prompted a shift from the 
use of free chlorine to chloramine as a final disinfectant in many US water utilities 
(Krasner et al., 1989; Seidel et al., 2005; USEPA, 2012; Zhang et al., 2000). Later studies 
showed that even though chloramination produced less of the regulated DBPs, it led to 
the formation of unregulated, and concerning DBPs (Krasner et al., 2006; Kristiana et al., 
2009; Plewa et al., 2004b; Richardson et al., 2008; Weinberg et al., 2002;).  
 Recent toxicity literature has shown that as a group, iodinated-DBPs (I-DBPs) are 
more cyto- and genotoxic than brominated-DBPs, which are in turn more cyto- and 
genotoxic than chlorinated-DBPs in Chinese Hamster Ovary (CHO) cells (Hunter and 
Tugman, 1996; Plewa et al., 2008; Plewa et al., 2010; Richardson et al., 2008). Therefore, 
breaking down the parameter TOX into its individual halogens can be extremely 
informative. Similar to the use of TOX, total organic chlorine (TOCl), total organic 
bromine (TOBr), and total organic iodine (TOI) have been adopted as surrogates for total 
chlorinated, brominated, and iodinated organics in water sources, respectively (Hua and 
Reckhow, 2006; Hua and Reckhow, 2007; Hua et al., 2006; Kristiana et al., 2009; 
Oleksy-Frenzel et al., 2000). The focus of this work is on TOI partly because of the 
growing toxicity literature that places I-DBPs among the most toxic of all halogenated 
DBPs. Currently, there is a need for a method that is rapid and sensitive and can capture a 
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wide range of iodinated organics in water. The lack of a good method had contributed to 
a void in understanding the behavior of TOI in real water systems. To be able to fill this 
void, a method for TOI measurement in water that meets those objectives should be 
developed. In this work, an improved TOI method is developed that builds on previous 
methods, yet is optimized to offer the highest sensitivity and applicability. With the 
availability of such a method, we will be able to accurately quantify and characterize TOI 
in raw and disinfected water samples. This enables us to explore the occurrence, 
magnitude, and seasonality of TOI in real water systems. Having a large scale 
understanding of TOI in real water systems makes it possible to relate TOI to the physical 
and chemical parameters that are routinely measured in treated waters. The ultimate goal 
of this line of work would be to better estimate TOI occurrence in treated water using 
these parameters in the absence of advanced analytical techniques. 
 The foundation of most of the aforementioned toxicity literature on DBPs in 
general and I-DBPs in particular has been built on results from CHO cells. Since natural 
heterogeneity warrants that the effect of the same toxicant will vary between species, the 
responses observed in CHO cells cannot necessarily be extended to humans. This gives 
rise to the need to study human cell lines that can be directly related to the available 
epidemiological evidence. In this study, we tested the impact of six I-DBPs on healthy 
human colon epithelial cells. Not only can this work serve to complement the existing 
literature on CHO cells, it should also be a starting point and a building block for an 
extensive toxicity study of I-DBPs and other halogenated DBPs using this cell line. The 
hope is that this cell culture can be used to guide future water treatment approaches to 
minimize the public health risk associated with DBPs exposure through drinking water.
 1 Modified from originally published version (Sayess, R. & Reckhow, D. A., 2017. Improved method for 
total organic iodine in drinking water. Water Res., 108, 250-259.) 
 
CHAPTER 2 
 
AN IMPROVED METHOD FOR TOTAL ORGANIC IODINE IN DRINKING 
WATER1 
 
2.1 Introduction 
 
 The use of chlorine as a chemical disinfectant to purify drinking water is one of 
the most important public health achievements of the twentieth century, having led to a 
significant decrease in water-borne diseases in the U.S. (Center for Disease Control and 
Prevention, 1999). However, the non-selective properties of powerful oxidants such as 
chlorine, ozone, and chlorine dioxide means that they not only act on pathogens, but they 
also oxidize natural organic matter (NOM), bromide, and iodide naturally present in 
source waters to form halogenated disinfection by-products (DBPs). Moreover, organic-
bound sources of iodine in raw waters may participate as well.  For example, iodinated 
X-ray contrast media (ICM) commonly used in medical imaging are poorly removed in 
wastewater treatment and as a result, they have been detected in rivers and streams 
(Carballa et al., 2004; Oleksy-Frenzel et al., 2000; Putschew et al., 2001; Putschew and 
Jekel, 2006), as well as in groundwater and drinking water (Drewes et al., 2001; Hirsch et 
al., 2000; Putschew et al., 2001; Sacher et al., 2001; Ternes et al., 2003; Schittko et al., 
2004). These compounds have the ability to react with the added disinfectants during 
treatment, releasing iodine and forming iodinated-DBPs (I-DBPs). 
 The complex nature of organic matter in chlorinated and chloraminated water 
leads to the formation of a large number of halogenated-DBPs that cannot all be 
individually identified and quantified. Measures of total organic chlorine (TOCl), total 
organic bromine (TOBr), and total organic iodine (TOI) have been commonly adopted as 
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surrogates for total chlorinated, brominated, and iodinated organics in water sources, 
respectively (Oleksy-Frenzel et al., 2000; Hua and Reckhow, 2006; Hua and Reckhow, 
2006; Hua et al., 2007; Kristiana et al., 2009), in a similar manner to the use of total 
organic halide, or TOX, as a surrogate for the sum of all halogenated organics (Li et al., 
2002; Reckhow et al., 1990; Richardson, 2003). Since I-DBPs are of particular concern 
due to their elevated cyto- and geno-toxicity compared to their brominated and 
chlorinated analogs (Hunter and Tugman, 1996; Plewa et al., 2008; Plewa et al., 2010; 
Richardson et al., 2008), there is increasing interest in the measurement and tracking of 
TOI as a surrogate for the total amount of iodinated organics in disinfected water.  
 The most widely used methods for TOI measurement entail the adsorption of the 
organic iodine in an acidified water sample (pH~2) onto activated carbon, pyrolysis of 
the organic iodine to form hydrogen iodide (HI) off-gas, and collection of the HI into an 
aliquot of water (trap solution). For iodide detection and separation from the aliquot of 
water, the use of either offline ion chromatography (IC; Hua and Reckhow, 2006; 
Kristiana et al., 2009; Oleksy-Frenzel et al., 2000) or offline ultra-performance liquid 
chromatography/electrospray ionization-mass spectrometry (UPLC/ESI-MS; Ding and 
Zhang, 2009; Gong and Zhang, 2015; Pan and Zhang, 2013) have been used. Both 
detection methods have drawbacks. The standard IC method has poor sensitivity for 
iodide (method detection limit of about 100 µg/L as I). Although iodide sensitivity can be 
improved by using a proper ratio of sample volume to trap solution volume (Kristiana et 
al., 2009), an IC run takes about 25 minutes per sample, precluding its routine analysis. 
The UPLC/ESI-MS detection method showed improvements over standard IC with faster 
analysis, better sensitivity (method detection limit of 3.7 µg/L as I), and higher 
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chromatographic resolution. However, it failed to detect iodide peaks for iopromide, 
designated by the authors as a representative of ICM compounds (Pan and Zhang, 2013). 
This raises questions regarding the use of UPLC/ESI-MS for the detection of some of the 
major ICM compounds. Considering that the presence of ICM compounds in raw water 
may lead to the formation of I-DBPs upon disinfection, the chosen method has to be able 
to detect these compounds.  
 The inductively coupled plasma – mass spectrophotometer (ICP-MS) has superior 
sensitivity for iodine (I) in comparison to other detection techniques (Takaku et al., 
1995). For that reason, many studies have utilized ICP-MS in various natural waters after 
separation of organic and inorganic halogens with high performance size exclusion 
(Gilfedder et al., 2010; Gilfedder et al., 2011; Heumann et al., 1998; Radlinger and 
Heumann, 2000; Radlinger and Heumann, 1997). The objective of this study was to 
develop and optimize a method that takes advantage of the superior sensitivity of ICP-
MS and therefore overcomes the limitations of previous methods. The proposed method 
entails adsorption, combustion, and trapping, with offline ICP-MS for iodide detection. 
Key to any TOI method is the ability to achieve near complete recovery of iodinated 
compound that represent those expected to form as DBPs, while exhibiting high rejection 
of inorganic forms of iodine (e.g., iodide, triiodide, iodate).   
2.2   Materials and Methods 
2.2.1   Instrumentation 
 The instrumentation for TOI analysis includes adsorption and combustion units 
and an off-line ICP-MS. The adsorption systems used were either an EFU 1700 Filtration 
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Unit (Euroglas BV, Delft, The Netherlands) or an XPREP-A6 (Trace Elemental 
Instruments, Delft, The Netherlands), both equipped with pressurized sample reservoirs 
and granular activated carbon (GAC) adsorption columns (CPI International, Santa Rosa, 
CA). The ECS 1200 combustion system (Euroglas BV, Delft, The Netherlands) includes 
a combustion glass tube, a boat sampler, a motor-driven boat sampler, a furnace, sulfuric 
acid scrubbers, a gas bubbler/diffuser and trap, and an oxygen gas supply (99.99% high-
purity grade). The ICP-MS (Perkin Elmer Elan 9000) was used for measuring iodide 
concentration in the trap solution. Argon (99.9 9% high-purity grade) was used as the 
carrier and reaction gas.  
2.2.2   Chemicals and reagents 
 Ultra-pure water was obtained by filtering de-ionized water with a resistivity 
greater than 18.3 MΩ.cm (Billerica, MA) and used in preparing procedural calibration 
standard solutions, laboratory reagent blanks, model compound solutions, and the ICP-
MS wash solutions. Potassium iodide (KI), sodium iodide (NaI), sodium iodate (NaIO3), 
and nitric acid (HNO3; 70%, Trace Metal grade, Certified ACS) were purchased from 
Fisher Scientific. Tetramethylammonium hydroxide (TMAH; 25% W/W aqueous 
solution, Electronic Grade 99.999%) was obtained from Alfa Aeser. The model 
compounds iodoacetic Acid (IAA, 98%), 2-hydroxy-3-iodo-5-nitropyridine (97%), and 3-
iodo-4-methylbenzoic acid (97%) were obtained from Aldrich Chemical Company, while 
bromoiodoacetic acid (BIAA, 90+%) and triiodoacetic Acid (TIAA, 90%) were 
purchased from CanSyn Chem Corp and Toronto Research Chemical, respectively. The 
three ICM model compounds iopromide, diatrizoic acid, and iopamidol were obtained 
from European Pharmacopeia, Sigma Chemical Company, and USP, respectively. 
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2.2.3   Experimental design 
 The new proposed method builds on some of the previous methods presented in 
Table 2.1. During method development, three experimental factors were varied across 
two levels each to find the optimal combination of levels, hereafter referred to as 
“treatment”, for TOI recovery. The factors include: (Factor 1) the pH of the solution prior 
to GAC adsorption; (Factor 2) the amount of TMAH added to the iodide trap solution; 
and (Factor 3) the choice of ICP-MS wash. A detailed description of the entire process 
along with the reasons behind choosing the three factors is presented below. 
Table 2.1: Summary of methods for TOX and TOX species 
Study Objective pH of 
sample to 
be 
adsorbed 
Nitrate wash Detection Reported 
concentration 
Oleksy-
Frenzel et 
al., 2000 
TOX 
speciation 
2 Yes IC Cl- equivalent 
Hua and 
Reckhow, 
2006 
TOX 
speciation 
2 Yes IC Cl- equivalent 
Kristiana 
et al., 2009 
TOX 
speciation 
2 Information 
not available 
IC Cl- equivalent 
Pan and 
Zhang, 
2013 
TOI 2 Yes UPLC/ESI-
MS/MS 
TOI 
This study TOI 2 or <1 No ICP-MS TOI 
2.3.3.1. Factor 1 (F1) – sample pH during adsorption  
 Both adsorption efficiency and compound stability are affected by pH.  In these 
experiments, the water sample to be analyzed was acidified using HNO3 to either pH = 2 
± 0.2 (Level 1) or pH < 1 (Level 2). During our experimental runs, the range of pH < 1 
corresponded to a pH range between 0.76 and 0.99. Decreasing the pH shifts speciation 
of acidic compounds to protonated forms which are more readily adsorbed by activated 
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carbon. Fifty mL of the acidified sample is then applied at a flow rate of 3 mL/min onto 
two consecutive GAC columns (𝐶𝑜𝑙#1	  𝑎𝑛𝑑	  𝐶𝑜𝑙	  #2). The two GAC columns are then 
sequentially placed in a ceramic boat that is introduced into a 1000 °C oven to be 
combusted in the presence of oxygen gas for 10 minutes. Upon combustion, the organic 
iodine is released as HI in the gas phase that gets carried through sulfuric acid scrubbers 
and into a custom-made absorber cell that contains about 15 mL of ultra-pure water (the 
trap solution). At the end of the trapping cycle, the trap solution is adjusted to 20 mL by 
rinsing out the walls of the absorber cell. 
2.2.3.2. Factor 2 (F2) – composition of the trap solution 
 The trap solution should be selected to retain all gaseous HI and keep the iodine 
in a form that is effective for subsequent analysis by ICP-MS.  An important 
consideration is that iodine is known for its volatile nature and its tendency to persist on 
interior surfaces in analytical instruments, and undergo slow release during analysis of 
subsequent samples. These “memory effects” can introduce substantial error, particularly 
in acidic solutions (Takaku et al., 1995). Often, memory effects can be partly mitigated 
by long wash periods between samples, but this is far from an ideal solution. To prevent 
this problem, previous studies have suggested preparing the samples in an alkaline 
solution to improve iodine retention and signal stability, and to reduce the memory effect 
(Baumann, 1990; Gélinas et al., 1998; Muramatsu and Wedepohl, 1998; Takaku et al., 
1995; Vanhoe and Van Allemeersch, 1993). The choice of TMAH in particular as the 
alkaline solution in this study was motivated by its small matrix effect and good stability 
with the ICP (Takaku et al., 1995). In addition, its use results in high pH values without 
increasing the salt concentration; a problem that can occur with the use of sodium 
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hydroxide (NaOH) or potassium hydroxide (KOH) (Shetaya et al., 2012). This lowers the 
possibility of salt deposition in the ICP torch and nebulizer. In this study, TMAH at 0.1% 
v/v (Level 1; equivalent to pH~10) or 2% v/v (Level 2; equivalent to pH~12) was added 
to the 20 mL trap solution, then analyzed offline using the ICP-MS. 
2.2.3.3. Factor 3 (F3) – composition of ICP-MS wash 
 For the choice of the ICP-MS wash solution, the literature varies in terms of what 
the best option is for iodine measurement. Various studies have used a range of 
percentages of acidic (mainly HNO3) or basic (KOH, ammonium hydroxide, and TMAH) 
ICP-MS washes (Bu et al., 2003; Hansen et al., 2011; Muramatsu and Wedepohl, 1998; 
Patriarca et al., 1999). Previous studies looking at iodine in a range of geological 
reference materials used diluted HNO3 as the ICP-MS wash and were able to produce 
stable and reproducible results (Michel and Villemant, 2003; Schnetger and Muramatsu, 
1996; Schnetger et al., 1998). Other studies that used TMAH as a sample solvent also 
used it as the wash solution at varying percentages and also produced sensitive and stable 
results (Mesko et al., 2010; Muramatsu and Wedepohl, 1998). In this study, we varied the 
wash solution between HNO3 at 2% v/v (Level 1) and TMAH at 0.1% v/v (Level 2).  
2.2.4 Experimental runs 
 TOI recovery across the three factors and each of their two levels is examined for 
a variety of samples to determine the effectiveness of each treatment. All eight treatments 
(Table 2.2) were tested in a full factorial design for eight different organic model 
compounds, two inorganic compounds, and a series of field water samples. These 
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different waters are described below. To account for any background iodine, an ultra-pure 
Milli-Q blank was analyzed along with each of the tested waters. 
Table 2.2: An overview of the experimental runs for every sample without 
duplication/triplication 
Treatment  Factor 1: pH of adsorbed 
sample 
Factor 2: Percentage 
(v/v) TMAH added 
Factor 3: ICP-MS 
wash 
1 ~2 0.1 HNO3 (2%) 
2 <1 0.1 TMAH (0.1%) 
3 ~2 2 HNO3 (2%) 
4 <1 2 TMAH (0.1%) 
5 ~2 0.1 TMAH (0.1%) 
6 <1 0.1 HNO3 (2%) 
7 ~2 2 TMAH (0.1%) 
8 <1 2 HNO3 (2%) 
2.2.4.1. Model organic compounds 
 Eight organic iodinated model compounds prepared at known concentrations were 
examined in duplicate under each of the 8 treatments to provide a direct measure of TOI 
recovery (Table 2.3). The compounds include three ICM compounds (iopromide, 
diatrizoic acid, and iopamidol), three iodinated DBPs (IAA, BIAA, and TIAA), in 
addition to 2-hydroxy-3-iodo-5-nitropyridine, and 3-iodo-4-methylbenzoic acid. Zhang 
and Minear (2002) used a quantitative structure-activity relationship (QSAR) to estimate 
the decomposition rate constant for TIAA of 50 day-1 (corresponding to a half-life of 
0.014 days) at a pH of 7 and a temperature of 23 °C. Therefore, we assumed that the 
TIAA had entirely decomposed to iodoform at the time of analysis.  
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Table 2.3: Summary of the inorganic and organic iodinated compounds used during 
method development 
Compound Name Molecular Formula Molecular 
Weight 
(g.mol-1) 
pKa Theoretical 
prepared 
concentration 
(µg.L-1 as I) 
Iopromide  C18H24I3N3O8 791.11 10.62 ± 0.7 213.2 
Diatrizoic acid  C11H9I3N2O4 613.91 0.92 ± 0.1 152.3 
Iopamidol  C18H22I3N3O8 777.08 10.87 ± 0.46 190.4 
Iodoacetic acid  C2H3IO2 185.95 3.18 ± 0.1 126.9 
Bromoiodoacetic 
acid 
C2H2BrIO2 264.84 1.67 ± 0.1 126.9 
1Triiodoacetic acid C2HI3O2 437.74 
(393.73 for 
iodoform) 
1.29 ± 0.41 114.2 
2-hydroxy-3-iodo-
5-nitropyridine 
C5H3IN2O3 265.99 6.62 ± 0.1 126.9 
3-iodo-4-
methylbenzoic acid 
IC6H3(CH3)CO2H 278.04 4.02 ± 0.1 126.9 
Iodide 𝐼0𝐼0 126.90 8.49 31.7 and 63.4 
Iodate 𝐼𝑂20 174.90 0.75 13.7 and 68.7 
2.2.4.2. Model inorganic compounds 
 Recovery of iodine by the TOI method was also determined for inorganic 
iodinated compounds to determine the extent of interference that might be caused by 
these compounds. For all 8 treatments, two inorganic compounds at two concentrations 
were tested in triplicates: NaI at 31.7 and 63.4 µg/L as I and NaIO3 at 13.7 and 68.7 µg/L 
as I.  
 After the full analysis of all 8 treatments was completed and the best treatment 
identified, solutions of KI and NaIO3 at three concentrations (50.8, 25.4, and 5.1 µg/L as 
I), and an equi-molar mix of both compounds at four concentrations (50.8, 25.4, and 5.1 
µg/L as I) were analyzed in triplicate using that method. This extra step was taken to 
determine the behavior of iodide and iodate species across a larger range of 
concentrations for the chosen method. 
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2.2.4.3. Field water samples 
 Three raw and nine treated water samples (from two river sources and three water 
treatment plants in the Northeastern US) were collected during two summer months in 
2015 for analysis. Ascorbic acid was added at 40 mg/L to each of the samples as a 
quenching agent. A brief summary of the physical and chemical characteristics of the 12 
water samples during the two summer months is presented in the Appendix (Table A.1). 
The concentration of TOI for each field water sample was analyzed in duplicates under 
each of the 8 treatments. Even though the true TOI concentration in the field water 
samples is unknown, these runs can still help determine whether: 1) there is a statistically 
significant difference in concentration between the treatments for field water samples; 
and 2) if these differences align with the patterns observed for the model compounds. If 
both of these conditions are met, the results will further support the findings of the 
analysis for model compounds. 
2.2.5. Instrument calibration procedure 
 Solutions of KI or NaI were prepared at an appropriate range of concentration and 
used as stock standard solutions. Instrument calibration curves were obtained by direct 
analysis of five to six inorganic iodide standards having a concentration range that covers 
expected TOI concentrations using the ICP-MS while varying Factors 2 and 3 depending 
on the treatment (Table 2.2). The data were fitted to a linear model by least squares 
regression with the intercept forced to zero. 
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2.2.6. Calculations 
 To calculate the concentration of TOI, the ICP-MS counts of the blank 
(𝐵𝑙𝑎𝑛𝑘	  𝑐𝑜𝑢𝑛𝑡89:#;	  and 𝐵𝑙𝑎𝑛𝑘	  𝑐𝑜𝑢𝑛𝑡89:#<) are subtracted from the ICP-MS counts of the 
sample (𝑆𝑎𝑚𝑝𝑙𝑒	  𝑐𝑜𝑢𝑛𝑡89:#;	  and 𝑆𝑎𝑚𝑝𝑙𝑒	  𝑐𝑜𝑢𝑛𝑡89:#<). The slope of the instrument 
standard calibrations of KI or NaI is used while taking into account the trap solution 
volume and the initial adsorbed volume (Eq. 2.1).  
 	  𝑇𝑂𝐼	  (CDE 	  𝑎𝑠	  𝐼) =IJKL:M	  89NOPQRS#T0U:JOV	  89NOPQRS#T W IJKL:M	  89NOPQRS#X0U:JOV	  89NOPQRS#X 	  ×	  PZJL	  [9:NP\9O	  ]9:NKM([PJO^JZ^	  8NZ]M	  [:9LM	  ×	  J^[9Z_M^	  [JKL:M	  ]9:NKM)  Eq. 2.1 
 
 Concentrations of TOI are calculated for all waters (model organic compounds, 
model inorganic compounds, and field water samples). For the model compounds with 
known initial concentrations, recovery or rejection can also be determined, while for field 
water samples, only the TOI concentration can be calculated, as the true value is not 
known. The individual recovery of the ith organic compound (𝑅\) was calculated as the 
percentage of the calculated TOI concentration (Eq. 2.1) to the theoretical iodine 
concentration prepared (Eq. 2.2). 
 𝑅\	  (%) = 𝑇𝑂𝐼	  (𝜇𝑔 𝐿	  𝑎𝑠	  𝐼)𝑇ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙	  𝐼𝑜𝑑𝑖𝑛𝑒	  𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛	  (𝜇𝑔 𝐿	  𝑎𝑠	  𝐼) ∗ 100    Eq. 2.2 
 
 For organic model compounds with high recovery under a given treatment, 
random measurement error can cause recoveries to be larger than 100%. While small 
deviations (± 5%) are not deemed problematic, large deviations might indicate a highly 
variable method that is unreliable. To account for these large deviations, a penalty 
approach was developed only for the eight organic model compounds to favor recoveries 
that were near 100% and penalize methods with recoveries that deviate greatly both 
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above and below 100%. This penalty is applied implicitly by conducting statistical 
analyses (described below) on a new quantity termed adjusted recoveries, 𝑥\	  (%), equal 
to the negative absolute value of the difference between 𝑅\ and 100 (Eq. 2.3). The 𝑥\ 
values will always be less than or equal to 0, with 0 reflecting an R of 100% and 
increasingly negative values indicating increasingly poor recoveries. The treatments that 
produce recoveries much smaller and larger than 100% will have lower values of 𝑥\. 
 𝑥\	  (%) = −|100 − 𝑅\|        Eq. 2.3 
  
 The adjusted recoveries are then standardized separately to get the mean 
standardized adjusted recovery 𝑦\ for each compound i, calculated as the difference 
between the adjusted recovery,	  𝑥\, and the mean adjusted recovery of compound i, 𝑥\, 
divided by the sample standard deviation of that compound, 𝑠l\ , across all treatments and 
duplicates (Eq. 2.4). Larger values of 𝑦 correspond to original recoveries that are closer 
to 100%. Standardization allows the comparison of all the compounds (upon pooling) by 
eliminating the systematic differences in mean recovery between the different compounds 
(i.e., have the mean adjusted recovery equal 0) and equalizing their standard deviations 
(i.e., have the standard deviation equal 1). This is particularly important when conducting 
statistical tests that use data pooled from all compounds.  
 𝑦\ = (𝑥\ − 𝑥\) 𝑠l\          Eq. 2.4 
 
 For inorganic compounds, the individual rejection of the ith compound (𝑅𝑗\) was 
calculated as the percentage of iodine recovery (Eq. 2.1) subtracted from 100 (Eq. 2.5). 
 𝑅𝑗\	   % = 100 −	  𝑅\	  (%)        Eq. 2.5 
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2.2.7. Statistical analyses 
 A three-way analysis of variance (ANOVA) test was performed on the eight 
model compounds, the two inorganic compounds, and the field water samples. More 
information on the ANOVA is found in the Appendix (Text, Statistical Analyses). In 
conjunction with the ANOVA tests, a Tukey’s post hoc test was conducted on the TOI 
recoveries and concentrations of all water samples. The purpose of the Tukey’s test is to 
compare and test the difference of the mean of one treatment with the mean of every 
other treatment. Importantly, the Tukey’s test can be used to verify the treatment that 
resulted in the highest mean adjusted recovery rate of TOI across all eight organic model 
compounds and the highest rejection of iodine across the inorganic compounds. All 
statistical analyses were conducted using the R statistical programming language. 
2.2.8. GAC breakthrough analysis 
 Under ideal conditions we expect 80% or more of the TOI to be retained on the 
first column (𝐶𝑜𝑙#1)	  and most of the remaining (i.e., 20% or less) to be retained on the 
second column	  (𝐶𝑜𝑙	  #2). Data diagnostics will be performed as a screening tool to 
isolate the samples that exhibited a high breakthrough from 𝐶𝑜𝑙#1	  to 𝐶𝑜𝑙#2	  indicating a 
retention ratio of 𝑆𝑎𝑚𝑝𝑙𝑒	  𝑐𝑜𝑢𝑛𝑡89:#;/𝑆𝑎𝑚𝑝𝑙𝑒	  𝑐𝑜𝑢𝑛𝑡89:#< of less than 2. This will be an 
indication of poor adsorption of the iodinated organics onto the two GAC columns and 
can act as another measure of performance for the proposed method.   
2.2.9. Method detection limit 
 The method detection limit (MDL) procedure was conducted on IAA after 
statistically determining the best TOI treatment. Seven IAA replicates having a 
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concentration of 5.08 µg/L as I (between 1-5 times the expected detection level) were 
processed through the entire analytical method within one day. The mean concentration 
and the standard deviation from this mean between the seven replicates were calculated 
using inorganic standards after subtracting the background TOI concentration in ultra-
pure water (pH = 0.99). The t-value at 99% confidence and n-1 degrees of freedom (t-
value = 3.143 for seven replicates) was multiplied by the calculated standard deviation to 
yield a statistical estimate of the detection limit; this estimate is the MDL. 
 
2.3 Results and Discussion 
2.3.1 Method development 
2.3.1.1. Model organic compounds 
 The recoveries (𝑅\) of the eight organic model compounds without any distinction 
between treatments are presented to highlight the variation in the range of values across 
all model compounds and to help identify any systematic differences in recovery between 
them (Fig. 2.1a). The overall median and mean recovery data show that some iodinated 
compounds, such as the 2-hydroxy-3-iodo-5-nitropyridine and the 3-iodo-4-
methylbenzoic acid, are inherently better detected than others compounds, such as the 
two iodoacetic acids (IAA and TIAA), after averaging out variations in the method 
development factors. However, the recovery data show how 2-hydroxy-3-iodo-5-
nitropyridine and 3-iodo-3-methylbenzoic acid can also deviate greatly above 100% 
recovery. This is reflected in adjusted recoveries (𝑥\) for these compounds, which extend 
well below the optimal (i.e., 0) value (Fig. 2.1b). In addition to systematic mean 
differences, the range of recoveries also differs across compounds. BIAA, iopromide, and 
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iopamidol all display a small range of recoveries, suggesting modest responses to the 
different treatments. On the other hand, compounds such as IAA and TIAA displayed a 
much wider range in recoveries. Upon pooling of the recoveries of all compounds, the 
three factors and their respective levels can be studied to better understand their 
influences on the recoveries (Fig. 2.1c) and the adjusted recoveries (Fig. 2.1d). The most 
noticeable conclusion is the improved and more stable recoveries and adjusted recoveries 
upon using a TMAH wash compared to using an HNO3 wash (Factor 3). The influence of 
the three Factors and their statistical significance will be considered next. 
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Figure 2.1: The recovery (R) of the eight model compounds (n=16 for each compound) 
regardless of the influence of factors and levels (a); the adjusted recovery (x) of the eight 
model compounds regardless of the influence of factors and levels (b); the recovery (R) 
of the eight different treatments upon pooling of all the compounds (c); and the adjusted 
recovery (x) of the eight different treatments upon pooling of all the compounds (d). The 
top and bottom of the box are 75th and 25th percentiles, respectively; the top and bottom 
of the whiskers are 90th and 10th percentiles, respectively; the line across the inside of 
the box is the median; and the circles beyond the whiskers represent outliers. 
 
 The standardized adjusted recoveries (𝑦\) of the eight model compounds were 
pooled to examine the overall effect of the three factors on recovery. A three-way 
interaction plot shows the independent effect of the Factors 1, 2, and 3 on the mean 
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standardized adjusted recovery pooled across the compounds (Figure 2.2). The pH 
(Factor 1) did not have a statistically significant effect on the pooled standardized 
adjusted recoveries of the model compounds (p-value = 0.24). This suggests that once the 
pH is lowered to 2, further depression in the pH does not result in better adsorption and 
subsequent recovery. For Factor 2, the concentration of TMAH in the trap solution (0.1% 
v/v versus 2% v/v) did not show a statistically significant difference in the mean 
standardized adjusted recoveries (p-value = 0.52). Previous studies have recommended 
the use of an alkaline matrix to control iodine vaporization (Reid et al., 2008; Tagami et 
al., 2006; Takaku et al., 1995). Our results indicate that the degree of alkalinity or pH 
beyond a certain point (i.e., > 0.1% v/v) in the solution itself did not affect the recovery 
of the model compounds. This agrees with Tagami et al. (2006) who found that varying 
TMAH concentrations (0 - 1.25% v/v) did not have an effect on iodine counts in the ICP-
MS. The ICP-MS wash (Factor 3) was the one factor that did have a highly significant 
impact on the pooled, standardized adjusted recoveries of the eight model compounds. 
The ANOVA test verified this observation with a p-value of 2x10-7. The Tukey’s test was 
used to confirm that the TMAH (0.1% v/v) wash resulted in a significantly better mean 
standardized adjusted recovery than the HNO3 (2% v/v) wash (p-value = 1x10-7). The 
reason behind the poor performance of the HNO3 wash could be attributed to iodine 
losses by volatilization in the spray chamber and nebulizer tubing walls that might occur 
in acidic conditions causing unstable recoveries (Al-Ammar et al., 2001; Julshamn et al., 
2001; Knapp et al., 1998; Vanhoe and Van Allemeersch, 1993). It is worth noting that 
there were no significant interactive effects among the three factors (smallest p-value > 
0.1). 
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Figure 2.2: A three-way interaction plot of the means of the standardized adjusted 
recovery, y, of all compounds upon pooling 
 
 While the pooled data analysis allows for greater statistical power in 
distinguishing the effects of method development factors, we also examined the impact of 
the three factors and their levels on the adjusted recoveries of individual model 
compounds. Since two of the three factors did not show a significant impact on the 
adjusted recoveries when data for all compounds were pooled, additional information for 
method development may be available through analysis of the compound-specific 
adjusted recoveries. Most of the compounds showed a statistical difference of Factor 3 in 
the standardized adjusted recovery (𝑦\) (Appendix, Table A.2). Among the eight 
compounds, three compounds, IAA, BIAA, and iopamidol, exhibited an improved 
standardized adjusted recovery when the pH was less than one (Factor 1; p-value < 0.05). 
At a pH this low, iodinated compounds become highly protonated, which might have 
caused higher adsorption of these particular compounds on the activated carbon.  
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2.3.1.2. Inorganic compounds 
 Aqueous solutions of sodium iodide at two concentration levels (32 and 63 µg-/L 
as I) and separate solutions of sodium iodate at two concentration levels (14 and 69 µg-/L 
as I) were analyzed to find the treatment that results in the greatest rejection of these 
inorganic forms of I. A three-way interaction plot of the effect of the three factors on 𝑅𝑗\ 
of both 𝐼0 and 𝐼𝑂20 is presented in Figure 2.3, with a distinction made between 𝑅𝑗\ for 
low and high initial concentrations of inorganic I. Upon pooling of the rejection results of 
both inorganic compounds at two different concentrations each, Factors 1 and 3 exhibited 
a significant change in rejection. At an adsorption pH of 2 (Factor 1) the recovery of 
inorganic iodine species was higher, presumably due to greater retention on the activated 
carbon (p-value < 0.01). The influence of pH was more prominent for iodide (p-value < 
0.1) than for iodate (p-value = 0.39). For Factor 3, the TMAH wash resulted in 
significantly higher rejection of both inorganic iodine species compared to the HNO3 
wash (p-value < 0.01). This is in line with other studies that showed that an increasingly 
acidic ICP-MS wash causes an increase in signal intensity (Takaku et al., 1995). 
Therefore, for inorganic compounds, a pH of 1 prior to adsorption onto the GAC, and a 
TMAH wash for the ICP-MS was the best treatment in terms of the rejection of inorganic 
iodine species.  
  23 
 
Figure 2.3: A three-way interaction plot of the three factors on the rejection of low 
concentrations of NaIO3 (a) and NaI (b), and of high concentrations of NaIO3 (c) and NaI 
(d) 
 
 To provide further confirmation and to examine possible interactions between 
inorganic iodine species, the best treatment was applied in triplicate to a set of prepared 
samples with a wider range of concentrations of iodide and iodate (5.1, 25.4 and 50.8 
µg/L as I, for each separately), and to a set of equi-molar mixtures of both species (5.1, 
25.4, and 50.8, µg/L as I). A 2% (v/v) TMAH in the trap solution was used since it was 
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more successful for some organic compounds as previously explained. For iodate, the 
recovered concentrations were 1.7 µg/L, 1.6 µg/L, and below detection limit for the 50.8, 
25.4, and 5.1 µg/L solutions, respectively. For iodide, the recovered concentrations were 
0.9, 1.4 (duplicate only), and 0.6 µg/L for the same concentrations, respectively. This 
indicates presence of a non-linear relationship between concentration of iodide or iodate 
and TOI rejection or recovery. This might imply that there are a small number of high 
energy sites within the activated carbon that strongly bind the iodide and iodate and then 
become quickly exhausted at high levels of inorganic iodine. 
2.3.1.3. Field samples 
 Concentrations of TOI, rather than recoveries, are reported in the Appendix 
(Table A.3) for the field water samples, as the true concentrations are unknown. The TOI 
concentrations were comparable among the raw and treated water samples. Due to their 
similarities, the data from the raw and treated water samples were pooled for further 
analysis. Although the amount of organic iodine originally present in field samples is 
unknown, preventing us from calculating TOI recovery, we can study the differences in 
the effects of the three factors on the pooled data in a three-way interaction plot (Fig. 
2.4). For Factor 1, an adsorption pH of 2 for the adsorbed samples resulted in a 
statistically higher concentration of TOI compared to an adsorption pH of less than 1 (p-
value < 0.001). Our previous observations showed that inorganic iodide tends to get 
retained on the activated carbon at a pH of 2; this would explain the elevated TOI 
concentration in natural waters that contain iodide and iodate. To prevent this undesired 
outcome, a pH of less than 1 for the adsorbed samples is favored for field samples. For 
Factor 2, a slight increase in measured TOI was observed while using 2% (v/v) TMAH in 
  25 
the trap solution compared to 0.1% (v/v) TMAH, however, this difference was not of 
high significance (p-value = 0.07). The presence of inorganic iodine species in the field 
samples may have contributed to slightly higher concentrations of TOI for the HNO3, 
however, the choice of ICP-MS wash (Factor 3) was not statistically significant (p-value 
= 0.16). It is worth mentioning that there were no interaction effects between the three 
factors. 
 
 
Figure 2.4: A three-way interaction plot of the three factors on the average TOI 
concentration in field water samples for July and August. 
2.3.2 Breakthrough analysis 
 The retention ratio was assessed on tests with the eight organic compounds and 
the field samples to determine the extent of breakthrough (Fig. 2.5). The retention ratio 
was defined as the ratio of TOI from the first activated carbon column to the second one. 
A 𝐶𝑜𝑙#1/𝐶𝑜𝑙	  #2 ratio of 2 or below was considered to represent excessive breakthrough. 
For adsorption pH=2, two of the ICM compounds (diatrizoic acid and iopamidol) 
exhibited a high breakthrough (<2). The higher adsorption pH also resulted in poor 
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performance for field samples as about 30% of the samples had a high breakthrough 
under these conditions. This was not the case for the low pH of adsorption (< 1) where all 
eight organic compounds and 96% of field samples exhibited a retention ratio greater 
than 2.  
 
 
Figure 2.5: Retention ratio of the eight organic compounds and the field water samples. 
The cut-off point is a retention ratio of Col#1/Col #2 of 2. 
2.3.3 Preferred method 
 The result from organic and inorganic compounds and field water samples 
throughout the method development procedure led us to choose the following conditions 
for our preferred TOI method (Appendix, Figure A.1): 1) sample pH <1 prior to 
adsorption to minimize iodide retention on the activated carbon and to ensure the least 
breakthrough for field samples; 2) TMAH of 2% (v/v) in the trap solution prior to ICP-
MS analysis since it showed slightly higher recovery of certain model iodinated organic 
compounds; and 3) a TMAH (0.1% v/v) wash for the ICP-MS since that wash showed 
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greatly improved recovery compared to the HNO3 wash upon pooling of all the 
compounds, and the highest rejection of inorganic iodine species. 
2.3.4. Method detection limit 
 The MDL for the preferred method was determined to be 0.95 µg/L as I, 
calculated from the analysis of seven replicates with a nominal TOI concentration of 5.08 
µg/L. The MDLs for TOI reported in the literature include 2 µg/L (Kristiana et al., 2009), 
3.7 µg/L (Pan and Zhang, 2013), and 10.3 µg/L (Hua and Reckhow, 2006). Therefore, to 
the best of our knowledge, this is the lowest MDL yet reported for any TOI method. The 
coefficient of variation (CV), for the seven replicates used for the MDL determination 
was 0.059. 
 
2.4. Implications for water treatment 
  
 The preferred method for TOI measurement entailed lowering the sample pH to 
less than 1 prior to adsorption onto two GAC columns, adding TMAH at 2% (v/v) to the 
trap solution prior to ICP-MS analysis, and using a TMAH (0.1% v/v) ICP-MS wash. 
This method: 1) recovered a wide range of I-DBPs, ICM compounds, as well as other 
iodinated organic compounds; 2) achieved the highest rejection of inorganic iodine 
species compared to the other tested treatments; and 3) was successfully implemented on 
field samples with minimum breakthrough. Using this method, ambient levels of total 
organic iodine can be easily measured, even in systems with low total iodine. 
 Given the growing interest in TOI, mainly due to the emerging toxicity literature 
on I-DBPs, it is important to have a sensitive, reliable, and comprehensive method for 
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total iodinated organics present in a raw and treated water samples. Since that was 
achieved, we can attempt to fully understand, characterize, and predict TOI formation in 
actual water treatment systems. This will be consequently covered in Chapter 3. 
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CHAPTER 3 
 
OCCURRENCE OF TOTAL ORGANIC IODINE IN RAW AND 
CHLORAMINATED DRINKING WATER 
3.1. Introduction 
 Disinfection by-product (DBP) formation due to the chemical disinfection of 
drinking water with powerful oxidants such as chlorine, chloramines, and chlorine 
dioxide has emerged as a prominent challenge for health agencies and water utilities. 
During disinfection, a myriad of organically-bound halogenated compounds form in 
chlorinated and chloraminated waters due to the complex and diverse nature of natural 
organic matter (NOM), and all cannot be feasibly identified and quantified individually. 
Instead, the parameter TOX (total organic halogen) has been accepted as a surrogate 
measure of the sum of all halogenated DBPs, or compounds that are organically-bound to 
chlorine, bromine, and iodine in a water sample (Li et al., 2002; Reckhow et al., 1990; 
Richardson, 2003). Similarly, the surrogates total organic chlorine (TOCl), total organic 
bromine (TOBr), and total organic iodine (TOI) have been adopted to account for 
chlorinated, brominated, and iodinated DBPs (I-DBPs) in a water sample, respectively 
(Oleksy-Frenzel et al., 2000; Hua and Reckhow, 2006; Hua and Reckhow, 2007; Hua et 
al., 2006; Kristiana et al., 2009). 
 In drinking water treatment plants, the use of chloramines as a final disinfectant 
produces considerably lower levels of regulated DBPs when compared to free chlorine 
(Krasner et al., 1989; Zhang et al., 2000). Consequently, to conform to the Stage 2 
Disinfectant and Disinfection Byproduct Rule (USEPA, 2003), many water utilities in the 
US shifted from the use of free chlorine to the use of chloramines as a final disinfectant 
(Seidel et al., 2005; USEPA, 2012). Later studies showed that even though 
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chloramination produced less of the regulated DBPs, it produced more I-DBP species 
than free chlorine (Krasner et al., 2006; Weinberg et al., 2002; Kristiana et al., 2009; 
Plewa et al., 2004b; Richardson et al., 2008; Wang et al., 2016). This occurs because 
monochloramine does not oxidize hypoiodous acid (HOI) to iodate as rapidly as free 
chlorine does, favoring the slow reaction of HOI with NOM to form I-DBPs (Bichsel and 
von Gunten, 1999; Bichsel and von Gunten, 2000). This is especially true in source 
waters containing high concentrations of bromide, iodide and iodate, and organic iodine 
(Allard et al., 2015; Bichsel and von Gunten, 2000; Criquet et al., 2012; Krasner et al., 
2006; Richardson et al., 2008; Wang et al., 2016; Weinberg et al., 2002).  
 I-DBP formation is an emerging public health concern, especially since of the 
fifteen I-DBPs that have been identified in chlorinated and chloraminated water (Bichsel 
and von Gunten, 1999; Brass et al., 1977; Cancho et al., 2000; Chu et al., 2012; Glaze et 
al., 1975; Jeong et al., 2015; Krasner et al., 2006; Plewa et al., 2004b, 2008; Richardson, 
2003; Weinberg, 2002), all but one have been associated with higher cyto- and geno-
toxicity compared to their brominated and chlorinated analogues in mammalian cell 
systems (Hunter and Tugman, 1996; Jeong et al., 2015; Plewa et al., 2008, 2010; 
Richardson et al., 2008). Therefore, quantifying and characterizing TOI in disinfected 
and particularly in chloraminated waters is imperative. 
 Due to the recent developments in the I-DBP toxicity literature, there has been 
growing interest for TOI quantification in lab-treated (synthetic) and natural waters. 
Oleksy-Frenzel et al. (2000) used ion chromatography (IC) to differentiate between the 
three organically-bound halogens (TOCl, TOBr, and TOI) in the influent and effluent of a 
wastewater treatment plant. The TOI concentrations measured were of municipal and 
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hospital wastewater having high TOI concentrations (28-3060 µg/L as I). The standard IC 
method has poor sensitivity for iodide (method detection limit (MDL) of about 100 µg/L 
as I). Although the sensitivity can be improved by using a proper ratio of sample volume 
to trap solution volume (Kristiana et al., 2009), an IC run takes about 25 minutes per 
sample, precluding its routine analysis. A few studies have also looked at the 
simultaneous formation and speciation of the three TOX species (TOCl, TOBr, and TOI) 
in water (Hua and Reckhow, 2006; Hua and Reckhow, 2007; Hua et al., 2006; Kristiana 
et al., 2009; Yang et al., 2014). These preliminary studies focused primarily on method 
development for TOX speciation (Hua and Reckhow, 2006), formation and speciation of 
TOX in laboratory chlorinated (Hua et al., 2006; Yang et al., 2014) and chloraminated 
natural (Yang et al., 2014) and simulated drinking waters (Zhu and Zhang, 2016), and 
laboratory chlorinated and chloraminated NOM isolates (Kristiana et al., 2009) while 
adding variable amounts of iodide and bromide to the raw water. More recently, a new 
TOI method was developed that uses ultra-performance liquid chromatography 
/electrospray ionization-mass spectrometry (UPLC/ESI-MS) for iodide detection having a 
MDL of 3.7 µg/L as I (Pan and Zhang, 2013). This method was used to measure TOI in 
10 tap water grab samples in China (Pan and Zhang, 2013; Gong and Zhang, 2013). To 
date, no attempts have been made to measure and characterize TOI ocurrence in drinking 
water treatment plants (WTPs) and their respective distribution systems without halogen 
augmentation. Additionally, since all of the studies were implemented either on lab-
treated (synthetic) waters or on one-time grab water samples, there is a gap in our 
understanding of how TOI forms in real-world engineered systems over extended periods 
of time. 
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 To the authors’ knowledge, this work presents the first full-scale study of several 
drinking WTPs in the US that explores the occurrence of TOI in raw and chloraminated 
drinking water without the addition of iodine or bromine sources. A recently developed, 
highly sensitive method (MDL 0.95 µg/L as I) was used for TOI determination (Sayess 
and Reckhow, 2017). In the context of the aforementioned knowledge gaps, we 
characterize the magnitude and seasonal behavior of TOI and the contribution of TOI to 
total iodine (TI) concentrations in three WTPs. We use that information to pose the 
following three hypotheses: 1) TOI concentration significantly increases upon treatment; 
2) the organic fraction of TI changes between raw and treated water; and 3) TOI 
occurrence is influenced by commonly measured physical and chemical properties in a 
treated water sample. The ultimate goal of this line of research is to better understand and 
predict the occurrence of TOI in treated water to enable water utilities to better assess the 
presence of iodinated organics in the absence of advanced analytical techniques.  
3.2. Materials and Methods 
3.2.1. Instrumentation 
 The instrumentation for TOI analysis includes adsorption and combustion units 
and an off-line inductively coupled plasma – mass spectrometer (ICP-MS). The 
adsorption systems used was either an EFU 1700 Filtration Unit (Euroglas BV, Delft, 
The Netherlands) or an XPREP-A6 (Trace Elemental Instruments, Delft, The 
Netherlands), both equipped with pressurized sample reservoirs and granular activated 
carbon (GAC) adsorption columns (CPI International, Santa Rosa, CA). The ECS 1200 
combustion system (Euroglas BV, Delft, The Netherlands) includes a combustion glass 
tube, a boat sampler, a motor-driven boat sampler, a furnace, sulfuric acid scrubbers, a 
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gas bubbler/diffuser and trap, and an oxygen gas supply (99.99% high-purity grade). The 
ICP-MS (Perkin Elmer Elan 9000) was used for measuring iodide concentration in the 
trap solution for TOI measurement, as well as to measure the TI and total bromine (TBr). 
Argon gas (99.99% high-purity grade) was used as the carrier and reaction gas. All other 
analyses were done according to the Standard Methods for the Examination of Water and 
Wastewater (American Public Health Association, 1998).  
3.2.2. Chemicals and reagents 
 Ultra-pure water was obtained by filtering de-ionized water with a resistivity 
greater than 18.3 MΩ.cm (Billerica, MA) and used in preparing procedural calibration 
standard solutions, laboratory reagent blanks, model compound solutions, and the ICP-
MS wash solutions. Potassium iodide (KI; Certified ACS grade), sodium iodide (NaI; 
Certified ACS grade), sodium iodate (NaIO3; Certified ACS grade), potassium bromide 
(KBr; Certified ACS grade), and nitric acid (70%, Trace Metal grade) were obtained 
from Fisher Scientific. Tetramethylammonium hydroxide (TMAH, 25% W/W aqueous 
solution, Electronic Grade 99.999%) was obtained from Alfa Aeser.  
3.2.3. Field samples 
 All raw and treated water samples were collected from the same upstream and 
downstream locations throughout the sampling period in three WTPs (A, B, and C) and 
their distribution systems in the Unites States Environmental Protection Agency 
(USEPA) Ecoregion 3 (Figure 3.1). Ecosystems within the same ecoregions generally 
have similar quality, type, and quantity of environmental resources (USEPA, 2016). The 
“A” sampling train originates from a large river (basin of about 14,000 square miles) 
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while “B” and “C” originate from a small river (basin of about 2,000 square miles). Three 
raw waters (A-Raw, B-Raw, C-Raw) were collected from the intakes of the two rivers 
feeding into the three WTPs. At each of the WTPs, a water sample was collected from the 
point of entry into the distribution system (A-POE, B-POE, and C-POE), in addition to 
two points in the distribution system (A-DS1 and A-DS2, B-DS1 and B-DS2, and C-DS1 
and C-DS2). In all of the discussion to follow, we distinguish the treatment trains A, B, 
and C as “sites” and the sampling locations along a treatment chain (Raw, POE, DS1, 
DS2) as “locations.” In total, there were 12 samples (three raw and nine treated) collected 
for 3 months in 2014 (January, June, and July), and 12 consecutive months from May of 
2015 to April of 2016. Samples were collected within 1-2 days between the raw and 
treated waters. Although this indicates that the same plug of water is not followed 
throughout the distribution sampling train, we assume small changes in water quality 
within a range of a couple of days after confirming that the streamflow and precipitation 
data on the days of collection were similar. 
 
Figure 3.1: A schematic of the 12 sampling locations with respect to the three sites (not to 
scale) 
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 The treatment process in the three WTPs involves pretreatment, coagulation, 
settling, filtration and disinfection. Disinfection of the water is applied as chlorine at 
pretreatment and during coagulation, and after filtration as chloramine. More detailed 
information on the chlorination and chloramination for the three WTPs is presented in 
Table 3.1. Ascorbic acid was added to each of the collected samples as a quenching agent 
prior to being transported overnight using ice coolers to the University of Massachusetts, 
Amherst. The range of values of some of the physical and chemical characteristics 
collected over the 15 months are presented in the Appendix (Table A.4). 
Table 3.1: Information on chlorination and chloramination of the three intensively studied 
WTPs 
WTP Primary 
chlorination dose 
(mg/L) 
Ferric 
chloride 
dose (mg/L) 
Secondary 
chlorination dose 
(mg/L) 
Contact 
time 
(min) 
Ammonia 
dose (mg/L 
as N) 
Cl2/N 
A 2.6 30.6 2.2 65 0.64 3.7 
B 3.1 43 2.04 49 0.7 4.0 
C 1.8-4.2 43-53 2-3.5 66 0.7 Not specified 
 
 Grab samples from four other sites (D, E, F, and G) located in four other USEPA 
ecoregions (Regions 1, 4, 5, and 9) in the continental US were also collected during the 
summer months of 2015 and 2016 for comparative purposes (Table 3.2). Collecting 
samples from different USEPA ecoregions will allow us to study the impact of the 
inherent characteristics that are unique to each ecoregion on TOI concentrations. For each 
of the four sites, samples were collected from raw (surface) and treated (POE) waters, 
except for site D where the samples were collected from raw water and at a point in the 
distribution system (DS). WTPs E and G use chloramine as the final disinfectant prior to 
release into the distribution system, while WTPs D and F use only free chlorine. Water 
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from site G also underwent pre-ozonation in addition to free chlorine and ammonia 
addition. 
Table 3.2: Information on grab sample collection from the four other WTPs 
WTP EPA 
Ecoregion 
Samples Treatment Final disinfectant 
D 1 Raw and DS Coagulation, sedimentation, sand 
filtration 
Free chlorine 
E 4 Raw and 
POE 
Pre-free chlorine, coagulation, 
sedimentation, sand filtration 
Chloramine 
F 5 Raw and 
POE 
Coagulation, sedimentation, sand 
filtration 
Free chlorine 
G 9 Raw and 
POE 
Ozone, Pre-free chlorine, coagulation, 
sedimentation, sand filtration 
Chloramine 
3.2.4. Analyses 
 The detailed method for TOI analysis is described in Chapter 2 and in Sayess and 
Reckhow (2017). In short, samples were first acidified to a pH of less than 1. Fifty mL of 
the acidified samples was then adsorbed onto a module of two granular activated carbon 
(GAC) columns at a flow rate of 3 mL/min. The two GAC columns were then 
sequentially placed in a ceramic boat that is introduced into a 1000 °C oven to be 
combusted in the presence of oxygen gas for 10 minutes. Upon combustion, the organic 
iodine is released as HI in the gas phase that gets carried through sulfuric acid scrubbers 
and into a custom-made absorber cell that contains about 15 mL of ultra-pure water (the 
trap solution). At the end of the trapping cycle, the trap solution was adjusted to 20 mL 
by rinsing out the walls of the absorber cell. TMAH (2% v/v) was then added to the 20 
mL trap solution leading to a trap solution pH of about 12. The trap solution was then 
analyzed using the ICP-MS. The ICP-MS wash solution used was TMAH at 0.1% v/v. To 
account for any background iodine, an ultra-pure Milli-Q travel blank was analyzed along 
with each set of tested samples. Solutions of KI or NaI were prepared at an appropriate 
range of concentration and used as stock standard solutions. Instrument calibration curves 
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were obtained by direct analysis of five to six inorganic iodide standards having a 
concentration range that covers the expected TOI concentrations using the ICP-MS. The 
data were fitted to a linear model by least squares regression with the intercept forced to 
zero. This TOI method has a MDL of 0.95 µg/L and a coefficient of variation of 5.9%.  
 The ICP-MS instrument was also used to determine TI and total bromine (TBr). 
Samples being analyzed for TI and TBr were first adjusted by adding 0.1% v/v of TMAH 
to the samples prior to their direct injection into the ICP-MS. Similar to TOI analysis, 
procedural calibration standards of the inorganic halogens were used to calculate the 
concentration of TI and TBr after accounting for the concentrations of the iodide and the 
bromide in ultra-pure Milli-Q blanks. The MDL for TI and TBr using the ICP-MS is 0.19 
and 0.98 µg/L as I and as Br, respectively. 
 The different physical and chemical parameters measured and their associated 
measurement methods are presented in Table 3.3. Specific UV254 absorbance (SUVA254) 
was calculated as follows (Eq. 3.1): 
 𝑆𝑈𝑉𝐴	  ( EKD0K) = (𝑈𝑉<qr ∗ 100) 𝐷𝑂𝐶      Eq. 3.1 
Table 3.3: Physical and chemical parameters measured and their associated 
methodologies 
Parameter Method or Instrument 
Total organic carbon (TOC) and dissolved organic carbon (DOC) Standard Method 5310B (APHA 
et al., 1995) 
pH Standard Method 4500-H+.B. 
(APHA et al., 1995) 
Ammonia-nitrogen (NH3-N) Standard Method 4500-NH3.D. 
(APHA et al., 1995) 
Nitrate-nitrogen (NO3-N) EPA 300.0 (EPA, 1993) 
Temperature (T) Calibrated thermometer 
UV254 Standard Method 5910B (APHA 
et al., 1995) 
Total nitrogen (TN) Shimadzu TOCV 
Conductivity Standard Method 2520B (APHA 
et al., 1995) 
Combined chlorine residual (TCl2) Standard Method 4500-Cl G. 
(APHA et al., 1995) 
Chloride EPA 300.0 (EPA 1993) 
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3.2.5. Calculations 
 To calculate the concentration of TOI, the ICP-MS counts of the travel blank 
(𝐵𝑙𝑎𝑛𝑘	  𝑐𝑜𝑢𝑛𝑡89:#;	  and 𝐵𝑙𝑎𝑛𝑘	  𝑐𝑜𝑢𝑛𝑡89:#<) are subtracted from the ICP-MS counts of the 
sample (𝑆𝑎𝑚𝑝𝑙𝑒	  𝑐𝑜𝑢𝑛𝑡89:#;	  and 𝑆𝑎𝑚𝑝𝑙𝑒	  𝑐𝑜𝑢𝑛𝑡89:#<). The slope of the instrument 
standard calibrations of KI or NaI is used while taking into account the trap solution 
volume and the initial adsorbed volume (Eq. 3.2).  
 𝑇𝑂𝐼	  (CDE 	  𝑎𝑠	  𝐼) = IJKL:M	  89NOPQRS#T0U:JOV	  89NOPQRS#T W IJKL:M	  89NOPQRS#X0U:JOV	  89NOPQRS#X 	  ×	  PZJL	  [9:NP\9O	  ]9:NKM([PJO^JZ^	  8NZ]M	  [:9LM	  ×	  J^[9Z_M^	  [JKL:M	  ]9:NKM)   
Eq. 3.2. 
3.2.6. Data screening 
3.2.6.1. GAC breakthrough analysis 
 Data diagnostics were performed as a screening tool to isolate the samples that 
exhibited a high breakthrough from the first GAC column to the second 
(𝐶𝑜𝑙#1	  𝑎𝑛𝑑	  𝐶𝑜𝑙	  #2), indicated by a low retention ratio of 𝑆𝑎𝑚𝑝𝑙𝑒	  𝑐𝑜𝑢𝑛𝑡89:#;/𝑆𝑎𝑚𝑝𝑙𝑒	  𝑐𝑜𝑢𝑛𝑡89:#<. This will be an indication of poor adsorption of the iodinated 
organics onto the two GAC columns. We have excluded any samples with a retention 
ratio less than 2. This resulted in the exclusion of 12% of the samples. 
3.2.6.2. Outliers 
 An additional step was taken to exclude outliers in the data. For the purpose of 
this study, outliers are identified based on whether the TI value is less than the TOI value, 
allowing for some deviation based on TOI measurement error (TI measurement error is 
comparatively small and ignored here). To quantify measurement error for TOI, the 
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coefficient of variation (CV) was first calculated from a previous data set of duplicates of 
iodinated model organic compounds (Sayess and Reckhow, 2017) as well as duplicates 
from two months of the current TOI data set. Here, one CV value is calculated for each 
duplicate. The mean CV across duplicates was then calculated separately for both 
datasets: 0.12 and 0.10 for the real water samples and model compounds, respectively. 
Their average CV value (0.118) was used to calculate an estimate of the standard 
deviation (SD) of each TOI value in the current dataset. Finally, samples were excluded if 
the lower bound of a 95% confidence bound (TOI - 1.96*SD) was larger than the 
associated TI measurement. This resulted in the exclusion of 2% of the samples. 
3.2.7. Data analysis 
3.2.7.1. Occurrence 
 To characterize the occurrence of TOI in chloraminated samples, several types of 
observations will be presented, including the order of magnitude of TOI in raw and 
treated waters, as well as its seasonal variability. These data will be presented along with 
TI for the same samples. For comparison purposes, we will present the concentrations of 
TOI from raw and treated grab samples from four other sites representing four other 
ecoregions in the continental US. We also examine the ratio of TOI to TI in order to 
develop a better estimate of the distribution of inorganic iodine (iodide and iodate 
species) and organic iodine in fresh water sources and their respective treated waters in 
the Northeast US. For all comparisons of TOI and TI concentrations across sites or 
months, an analysis of variance (ANOVA) was conducted to establish the statistical 
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significance for mean differences, and a Tukey’s post hoc test is used to verify the 
direction of those differences. 
3.2.7.2. Influence of treatment 
 Since sampling in a given month did not follow the exact same plug of water from 
raw through to the treated samples, we pooled the results from all of the 15 months into a 
single statistical testing framework. This will allow us to study whether, on average, TOI 
significantly changes upon treatment. One approach to test this hypothesis would include 
multiple t-tests between the raw and different downstream (POE, DS1, DS2) samples, but 
this multiple-comparison approach would augment Type I error (i.e., incorrectly rejecting 
the null hypothesis that there is no change in TOI concentration between the raw and 
treated water). Therefore, a one-way ANOVA is conducted to avoid multiple 
comparisons. This permits us to test the difference in mean TOI concentration depending 
on the location in the distribution system (Raw, POE, DS1, and DS2). Separate ANOVA 
tests are conducted for sites A, B, or C due to differences in the mean and variance of 
TOI across the sites. The particular locations within the distribution system will be the 
four levels in the ANOVA. In the ANOVA, the general term 𝑦\t is used to represent the 
jth observation on the ith location (i= 1, 2, 3, and 4 level) representing the four locations 
within a sampling train (Eq. 3.3).  𝑦\t 	  = 𝜇 + 𝜏\ + 𝜀\t         Eq. 3.3  
 Here, 𝜇 is the overall mean of the observations, 𝜏\ represents the ith location 
effect, and	  𝜀\t is the random noise/error component present in the jth observation on the ith 
location. If there is a statistical difference in the average TOI between any of the four 
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locations, this would indicate that the average TOI concentration in the raw water is 
different from at least one of the locations downstream. Then, in conjunction with the 
ANOVA tests, a Tukey’s post hoc test was conducted to compare and test the difference 
of the mean of one location with the mean of every other location to determine the 
direction of differences in TOI between raw and treated waters.  
 In addition to TOI, we perform a similar analysis on TI and on the ratio of TOI to 
TI in the raw and treated waters. This will help determine whether the total amount of 
iodine or the speciation of iodine between inorganic and organic forms changes 
significantly under treatment. 
3.2.7.3. Relationship with commonly measured parameters 
 Another objective of this work is to explore the existence of a relation between 
TOI and some of the physical and chemical parameters that are commonly measured 
during routine water quality analyses. Our focus here is placed on the treated water 
samples since we are interested in the quality of the water that reaches the consumer. 
Therefore, for the purpose of this analysis, the raw water samples were not included. To 
test this hypothesis, we employ a multiple linear regression framework to relate TOI 
concentrations to a suite of physical and chemical properties. A step by step procedure is 
summarized here. The parameters (covariates) in the regression are shown in Table 3.4, 
along with the correlation coefficients between the various parameters. It is important to 
point out that several of the parameters are already highly correlated with one another, 
such as chloride and conductivity, and dissolved organic carbon (DOC) and total organic 
carbon (TOC). Collinearity among predictor variables increases the standard error on 
regression parameter estimates and reduces the ability to distinguish between significant 
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and insignificant predictors. A simple, yet effective approach to reduce collinearity in a 
regression framework is simply retaining some predictors over others if the correlation 
coefficient between the covariates is greater than some threshold value (Dorman, 2013). 
For interpretability, we adopt this simple approach, setting the threshold for Pearson r to 
0.6 and retaining predictors that are most likely to explain TOI variability from a 
mechanistic perspective (highlighted in bold in Table 3.4). The retained variables for the 
multiple linear regression framework were TI, temperature (T), pH, combined residual 
chlorine (TCl2), DOC, ammonia-nitrogen (NH3-N), specific UV254 absorbance 
(SUVA254), and chloride. 
Table 3.4: The correlation coefficients of the measured parameters with the ones in bold 
indicating the ones chosen for the regression analysis. Correlation coefficients greater 
than or equal to 0.2 are significant at the 0.01 level. 
 TI T pH Conductivity TCl2 TOC DOC UV254 NH3 -N NO3-N SUVA254 Chloride TBr TN 
TI               
T 0.6              
pH 0.2 0.1             
Conductivity 0.5 -0.1 0.4            
TCl2 -0.3 -0.2 0.0 -0.3           
TOC 0.6 0.4 0.3 0.5 -0.4          
DOC 0.5 0.4 0.3 0.5 -0.3 0.9         
UV254 0.6 0.6 0.2 0.4 0.0 0.7 0.7        
NH3-N 0.3 0.3 0.2 0.3 -0.5 0.4 0.3 0.4       
NO3-N 0.4 -0.3 0.3 0.9 -0.3 0.4 0.4 0.3 0.4      
SUVA254 -0.1 0.1 -0.1 -0.2 0.4 -0.5 -0.6 0.2 0.0 -0.3     
Chloride 0.1 -0.4 0.2 0.6 -0.2 0.2 0.3 0.1 0.2 0.6 -0.3    
TBr 0.6 0.3 0.3 0.5 -0.4 0.6 0.4 0.4 0.2 0.4 -0.2 0.2   
TN 0.4 0.2 0.3 0.8 -0.2 0.7 0.6 0.6 0.5 0.7 -0.2 0.7 0.5  
 
 The formulation of the multivariate regression is complicated by the measured 
TOI values that were below the MDL of 0.95 µg/L. While numerical values are available 
for these observations, the MDL renders them indistinguishable from background noise. 
  43 
Therefore, assigning the numerical values for these observations equal weight to the other 
observations in a standard regression will lead to inconsistent regression coefficient 
estimates (Amemiya, 1973). A Tobit model, a type of multivariate censored regression 
model, is used to correct for this and to assign the appropriate level of precision to these 
observations in the regression. Briefly, the Tobit model operates using maximum 
likelihood estimation instead of least squares. In the likelihood function, the probability 
density function (pdf) is evaluated for the residuals associated with the data above the 
MDL, since those residuals can be estimated precisely. For the data below the MDL, the 
residuals cannot be estimated precisely because the original data values are not known. 
For these residuals, we evaluate the cumulative distribution function (cdf) with 
integration limits determined by the MDL. In the likelihood function, the pdf values will 
naturally have more weight than the cdf values, giving more emphasis to the data we 
know more precisely. Similar to standard regression models, p-values can be used to test 
the significance of each covariate. The Tobit model was fit using the censReg library 
(Henningsen, 2011) in the R statistical programming language. After determining the 
statistically significant parameters on TOI concentration, the Tobit regression was refit 
using only those parameters. The R2 was calculated by assigning a value of half the MDL 
(0.475 µg/L) for values that were below the MDL (0.95 µg/L). The significance (p-value) 
of the final Tobit regression model was determined using a likelihood ratio test against a 
null model without any covariates. 
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3.3. Results and Discussion 
3.3.1. Occurrence 
 The TOI and TI concentrations at sites A, B, and C are examined first by pooling 
across months and sampling locations (Figure 3.2). The original, un-pooled TI and TOI 
data across sites, sampling locations, and months are shown in the Appendix (Figure 
A.2). For TI, the lower end of the concentration range was around 3 µg/L in the raw and 
treated water at all sites. The median TI concentration was 5 µg/L for site A, and 11 µg/L 
for sites B and C. The higher end of the concentration range was 11.5, 23.1, and 18.9 
µg/L for sites A, B, and C, respectively. Many studies have reported on TI concentrations 
in fresh water sources (Table 3.5). Takaku et al. (1995) reported on rivers in Kanto 
region, Japan, having TI values ranging between 0.65 and 35.9 µg/L. In the United 
Stated, TI values in some rivers ranged between 0.06 µg/L to 26.9 µg/L (Moran et al., 
1997; Moran et al., 1999; Moran et al., 2002; Oktay et al., 2000; Oktay et al., 2001). The 
TI concentrations in Lake Constance, Germany, and its tributaries ranged between 0.66 
and 10 µg/L, with the exception of the Steinach tributary which is known to have an input 
of iodinated X-ray contrast media compounds (Gilfedder et al., 2010). For treated waters, 
Gong and Zhang (2013) reported on TI concentrations in four chlorinated grab samples in 
four WTPs in China collected in August 2013 to be between 6.5 and 12.9 µg/L. In 
comparison, results from our grab samples for WTPs E, F, and G (the TI concentration 
for WTP D was not available) were between 4.9 and 14.26 µg/L in the raw water and 
between 3.5 and 8.3 µg/L in the treated water. Overall, the TI results obtained in our 
study are in line with those reported in the literature. 
  45 
Table 3.5: Comparison between the TI concentration in the literature and this study 
 TI concentration (µg/L) in raw 
waters 
TI concentration (µg/L) 
in treated waters 
Takaku et al., 1995 0.65 – 35.9 NA 
Gilfedder et al., 2010 0.6 – 10 NA 
Gong and Zhang, 
2013 
NA 6.5-12.9 
WTPs A, B, and C 
(this study) a 
3.7 – 19.2 2.5 – 23.1 
WTPs E, F, and G 
(this study) b 
4.9 – 14.2 3.5 – 8.3 
a The results of the extensive sampling over the 15-month period 
b The results of the grab samples 
 When examining TOI at site A, about half of the TOI values were below the MDL 
while the higher end of the range was about 4 µg/L for the raw and treated waters. The 
maximum TOI values observed for site B were 11.75 µg/L for the raw water and 17.7 
µg/L for the treated water, with a median of about 3 µg/L for both. For site C, maximum 
TOI concentrations in the pooled raw and treated waters reached about 10 µg/L, also with 
a median around 3 µg/L. By pooling across months and sampling locations, the results 
showed that site A had significantly lower TOI concentrations than sites B and C (p-value 
< 0.005). This relationship was also evident when assigning a value of half the MDL 
(0.475 µg/L) for the samples that had a TOI concentration below the MDL. The lower 
TOI concentration in site A could be seen as directly related to the amount of TI in the 
raw and treated water, which was significantly lower in site A as well (p-value < 0.001). 
The pooled TOI concentrations across the months and sampling locations did not show 
any statistical differences between sites B and C (p-value > 0.05). Considering that the 
same source water feeds into WTPs B and C that operate in a similar manner (Table 3.1), 
these results are not surprising. 
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 For comparison, the TOI concentration in the raw and treated water grab samples 
collected from four sites (D, E, F, and G) are presented in Table 3.6. The TOI 
concentration in the raw and treated waters from the four other sites ranged between 1 
and 4 µg/L. The order of magnitude of TOI presented for these sites and for the bulk of 
the samples collected for sites A, B, and C are in line with results of raw (Gilfedder et al., 
2010) and chlorinated grab tap water samples (Pan and Zhang, 2013; Gong and Zhang, 
2013) in the literature. The TOI concentration in Lake Constance, Germany, and its 
tributaries was calculated from TI and total inorganic iodine (TII) to be generally below 5 
µg/L, with the exception of the Steinach tributary which had a range of 2 to 68 µg/L 
(Gilfedder et al., 2010). For treated samples, TOI concentrations, measured using an 
UPLC-ESI/MS, were as low as 1.3 µg/L but reached up to 16.4 µg/L in chlorinated grab 
water samples (Pan and Zhang, 2013; Gong and Zhang, 2013; Pan et al., 2016). The 
skewness in TOI concentrations in treated samples in the literature is also observed at 
sites B and C, with a few TOI values substantially larger than the majority of 
measurements. Repeated sampling at these sites B and C suggest that limited grab 
samples may miss important spikes in TOI concentrations.   
 The ratio of TOI/TI at sites A, B, and C are examined next by pooling across 
months and sampling locations (Figure 3.2). The average ratios for sites A, B and C were 
roughly the same, with the mean ratio for site A (0.30) slightly lower than those for Sites 
B and C (0.35). Not only were the three sites similar in their means, but all three sites 
displayed highly variable ratios across the months and sampling locations. The inter-
quartile range for ratios varied between 0.04 and 0.50 for site A and between 0.15 and 
0.56 for sites B and C. On many occasions at all sites, spikes in TOI values were not 
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accompanied by spikes in TI and vice versa, leading to the high variability in ratio values 
(Appendix, Figure A.2). Results from WTPs E, F, and G (TI values for WTP D were not 
available) showed that the organic fraction ranged between 0.22 and 0.41. The results 
from all the WTPs are in line with the literature. For example, Heumann et al. (1998) 
reported organic iodine fractions of 0.23, 0.38, and 0.38 of TI in Rivers Nile, Regen, and 
Danube, respectively, using reverse phase chromatography/inductively coupled plasma-
isotope dilution mass spectroscopy (RPC/ICP-IDMS). However, the authors reported that 
this method may have missed high molecular weight or volatile organic species which 
would have increased the organic fraction of TI. Shwehr and Santschi (2003) reported 
that the organic iodine (calculated as the difference between TI and TII) fraction in fresh 
surface water from the Trinity River, Texas, ranged between 0.07 to 0.64 of TI, with an 
average of 0.37 and a median of 0.42. Others reported an even bigger TOI fraction, 
reaching up to 1 in several natural fresh waters using an isotope dilution mass 
spectrometry that had a similar problem as RPC/ICP-IDMS (Reifenhäuser & Heumann, 
1990). Overall, the high variability in the organic fraction observed here is not 
uncommon. 
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Figure 3.2: The concentration of TOI (left), TI (center), and the ratio of TOI to TI (right) 
at sites A, B, and C pooled across the months and sampling locations. (left) The 
horizontal red line represents the TOI MDL of 0.95 µg/L. TOI values that were below the 
MDL (n=35) were assumed as half the MDL (0.475 µg/L). Ratios of TOI/TI that were 
slightly greater than 100% (see Section 3.2.6.2) were forced to 100% for clarity. The 
black star indicates significant difference between the sites (p-value < 0.05). 
 
Table 3.6: Concentration of TOI and TI and the ratio of TOI/TI in the grab raw and 
treated samples in the four other WTPs. 
WTP EPA Ecoregion TOI (µg/L) TI (µg/L) TOI/TI 
Raw POE or DS Raw POE or DS Raw POE or DS 
D 1 3.97 3.06 NA NA NA NA 
E 4 3.85 2.33 14.26 8.33 0.27 0.28 
F 5 1.09 1.27 4.95 3.48 0.22 0.36 
G 9 2.62 2.01 6.41 7.28 0.41 0.27 
  
 The results of TOI, TI, and ratio of TOI/TI for the fifteen months pooled across 
all sites and sampling locations are presented in Figure 3.3. We assume here that any 
systematic mean differences between sites A, B, and C or sampling locations are 
consistent across months. For TI, the primary seasonal pattern is characterized by higher 
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concentrations in the spring and summer months (April – September) compared to 
concentrations in the fall and winter months (October – March) (p-value < 0.001). This 
pattern, however, is not observed for TOI where the seasonal pattern is somewhat less 
clear. There is substantial inter-monthly variability in TOI measurements, in which high 
or low values of TOI cluster for 2-3 months at a time (July to August 2016, October to 
December 2016). Gilfedder et al. (2009) reported the highest formation of soluble organic 
iodine (calculated, not measured) in the humic rich Mummelsee Lake (DOC ~ 7 mg/L), 
Germany, between July and November. Apart from September, this pattern is similar to 
what has been observed in this study. Therefore, we conclude that there may be a cyclic 
pattern in TOI variability similar to that reported in Gilfedder et al. (2009), with peak 
values between the late summer and early winter, but additional years of data are 
necessary to confirm this pattern. The TOI/TI ratios become similarly elevated in the late 
summer and early winter, compared to the other seasons. The cyclic variability in TOI 
seems to highly influences the TOI/TI ratios as this ratio mostly follows the observed 
occurrence trends of TOI. 
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Figure 3.3: The concentration of TOI (top), the concentration of TI (middle), and the ratio 
of TOI to TI (bottom) for every month pooled across all sites and locations. The 
horizontal red line represents the TOI MDL of 0.95 µg/L. TOI values that were below the 
MDL (n=35) were assumed as half the MDL (0.475 µg/L). Ratios of TOI/TI that were 
slightly greater than 100% (see Section 3.2.6.2) were forced to 100% for clarity. The 
vertical black line separates the three 2014 sampling dates from the other twelve. 
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3.3.2. Influence of treatment 
 It is well established in the literature that I-DBPs form in chloraminated water. So 
far, the formation of six iodinated trihalomethanes (I-THMs) (Hansson et al., 1987; 
Bichsel and von Gunten, 2000; Krasner et al., 2006), five iodoacids (Krasner et al., 2006; 
Plewa et al., 2004; Wei et al., 2013), two iodoacetaldehydes (Krasner et al., 2006), and 
two iodoacetamides (Chu et al., 2012; Plewa et al., 2008) have been identified in 
chloraminated water. The hypothesis examined here was that the TOI in the raw water 
increases upon treatment due to the increase in I-DBP formation. To test this hypothesis, 
the influence of treatment on TOI concentration was explored at each of the sites (Figure 
3.4). Somewhat surprisingly, we only detect a significant change between TOI in the raw 
water and the treated water at site A (p-value = 0.0467). Sites B and C show no 
significant differences (p-value > 0.05). Moreover, the Tukey’s test showed that that 
change in TOI at site A was due to higher TOI concentration in A-Raw compared to A-
DS1 (p-value = 0.033), which ran counter to our expectation of higher TOI in the treated 
waters. It is important to note that half of the TOI samples for site A were below the 
MDL, so it is unclear whether this significance is conclusive. Overall, these results first 
show that TOI was present in the raw water. This observation is probably due to the 
reduction of iodate by soil organic matter. This produces reactive intermediate species 
(HOI and elemental iodine (I2)) that undergo rapid electrophilic substitution reactions 
with electron donor groups on the NOM leading to the formation of organic iodine 
species (Francois, 1987a; Fukui et al., 1996; Steinberg et al., 2008b; Whitehead, 1974b). 
Recently, Bowley et al. (2016) showed that both iodide and iodate react with humic acid 
(a fraction of NOM) in soils to produce organic iodine. They also showed that the humic 
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acid itself originally contained native sources of iodine, namely iodide and organic 
iodine. The presence of TOI in raw water due to these reactions is distinctive compared to 
TOBr and TOCl formation since the latter two do not form in the absence of chloramines 
and bromamines (Bichsel and von Gunten, 1999). The second observation was that TOI 
does not significantly increase or decrease upon treatment of the raw water samples. 
Given that previous research supports that I-DBPs form upon chloramination, the lack of 
change in TOI concentration between the raw and treated water suggest that the 
components of TOI may have shifted. That is, after treatment, there is a change in 
speciation in the contents of TOI from non-DBP iodinated organics to I-DBPs. If this 
holds true, it underscores the limitation of using a surrogate measure such as TOI since 
the components of the iodinated organics are not individually identified. 
 
Figure 3.4: Boxplot of TOI concentration at every sampling location pooled across the 
period of 15 months. The horizontal red line represents the MDL of 0.95 µg/L. TOI 
values that were below the MDL (n=35) were assumed as half the MDL (0.475 µg/L). 
The black star indicates significant difference between the locations (p-value < 0.05). 
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 We also explored the concentration of TI and the ratio of TOI to TI across 
sampling locations to test whether TI or iodine speciation between inorganic and organic 
species shifts between raw and treated water. The concentration of TI at each of the 
locations pooled across the months is presented in Figure 3.5. With respect to TI 
concentration, there was no statistically significant difference between the mean TI 
concentration in the raw water and that in every other treated sampling point at any of the 
three sites (p-value > 0.05). However, despite the ANOVA results, raw waters for sites A 
and C do exhibit somewhat lower TI concentrations compared to the treated waters, 
particularly in the upper and lower quartiles of the distribution.  
 
Figure 3.5: Boxplot of TI concentration at every sampling point pooled across the period 
of 15 months. 
 For the ratio of TOI to TI, a significant change between raw and treated waters is 
seen for site A, where the ratio of iodinated organics decreases significantly upon 
treatment (p-value < 0.005; Fig. 3.6). For example, the median ratio drops from 0.5 in 
Raw A to about 0.1 in the treated samples. A similar decreasing signal is seen in site C 
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and is near significant (p-value = 0.13), while no significant difference is seen for site B. 
The pooled results of the ratio of TOI to TI across all three sites indicate that the ratio of 
TOI/TI decreases upon treatment (p-value < 0.01). The decrease in the organic fraction 
upon treatment may indicate that during coagulation, flocculation, and settling processes 
within the WTP, some of the NOM that is bound to iodine is removed. 
 
 
 
Figure 3.6: Boxplot of TOI/TI at every sampling point pooled across the period of 15 
months. Ratios of TOI/TI that were slightly greater than 100% (see Section 3.2.6.2) were 
forced to 100% for clarity. The black star indicates significant difference between the 
locations (p-value < 0.05). 
3.3.3. Relationship with commonly measured parameters 
 Given the skewness in TOI concentrations seen in Figure 3.2, the TOI 
concentration data was log transformed prior to running the Tobit regression. This 
transformation produced more normally distributed residuals, which are needed for the 
interpretation of the significance tests for the regression parameters. The results of the 
Tobit regression are presented in Table 3.7. Of the eight chosen parameters (TI, T, pH, 
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TCl2, DOC, NH3-N, SUVA254, and chloride), four exhibited a significant relationship 
with TOI (p-value < 0.05). DOC and SUVA were highly significant (p-value < 0.0001 
and p-value < 0.005, respectively) with opposing trends since they are inversely 
proportional to one another, while TCl2 and pH were significant at the 0.05 level. 
Scatterplots of each of the individual predictors against the measured TOI values are 
presented in Figure 3.7.  
 The observed positive relationship between DOC and TOI is expected since upon 
chloramination of iodide-containing waters, HOI forms (Bichsel and von Gunten, 1999) 
which in turn reacts with NOM to form I-DBPs (Bichsel and von Gunten, 2000; 
Richardson et al., 2008; Hua and Reckhow, 2006; Karpel Vel Leitner et al., 1998). Allard 
et al. (2015) showed that at low DOC concentrations (1 mg/L), almost all of the iodide in 
the water is converted to iodate, the stable form of iodine. In contrast, at high DOC 
concentrations (4 mg/L), iodine binds to the many reactive sites within the NOM, 
forming iodinated organics before it can be converted to iodate. In general, the authors 
showed that at high DOC concentrations, a higher formation of iodinated organic 
compounds is expected. This is in line with what we observed in our study. 
 SUVA254 values indicate the nature and composition of NOM in a water sample 
(Edzwald and Tobiason, 1999) and have been shown to play a role in the type of DBP 
formation. Higher SUVA254 values (~4 or greater) imply high hydrophobicity, 
aromaticity, and molecular weight components, while low SUVA254 values (<2) indicate 
the opposite. SUVA254 values between 2 and 4 suggest mixtures of hydrophobic and 
hydrophilic, and aromatic and non-aromatic NOM with a mixture of molecular weights. 
During the 15 months, we observed SUVA254 values that were between 1.85 - 4.17 for the 
  56 
treated waters (Appendix, Table A.4). Chloramination experiments conducted by 
Kristiana et al. (2009) showed that the aromatic components within NOM played a major 
role in the formation of TOBr and TOCl, but not in the formation of TOI. The authors 
suggested that when the number of reactive sites in NOM have a high aromatic content 
(high SUVA254 values), hyprobromous and hypochlorous acids (known to be highly 
reactive with phenolic moieties), outcompete HOI in reactions with NOM (Criquet et al., 
2015; Echigo and Minear, 2006; Lee et al., 2005; Westerhoff et al., 2004). This fact could 
explain what we observed here: for the low to mid-range SUVA254 values observed in 
this study (1.85 - 4.17), TOI concentration decreases with an increase in SUVA254. Allard 
et al. (2015) observed similar results in chloraminated water, but attributed this to the 
chlorination/bromination of the active sites during the chlorine contact period.  
 After treatment, the pH of the samples was adjusted to between 6.93 and 7.45 
prior to release into the distribution system throughout the 15 months and across all three 
sites (Appendix, Table A.4). The effective pH range for monochloramine is between 7.5 
and 9. The further the pH drops below 7.5, monochloramine becomes less stable and is 
likely to dissociate into HOCl and NH3 (Deborde and von Gunten, 2008). In other words, 
decreasing the pH is expected to enhance the release of HOCl by the hydrolysis of 
NH2Cl. Since HOCl rapidly oxidizes HOI to iodate (the stable form) (Bichsel and von 
Gunten, 1999; Bichsel and von Gunten, 2000), it leads to lower formation of I-DBPs. 
This is consistent with what we observed in our study, where an increase in pH was 
accompanied by a subsequent increase in TOI concentration.  
 The effect of TCl2 on TOI concentration is examined next. Our results show that 
an increase in TCl2 concentration is accompanied by a decrease in TOI concentration. 
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This could be seen as a result of an equilibrium between chloramine and free chlorine 
achieved at sufficiently high TCl2 concentrations. Once equilibrium is achieved, HOCl 
starts slowly forming, which then leads to the rapid oxidation of HOI to form iodate 
(Bichsel and von Gunten, 1999; Bichsel and von Gunten, 2000). This has been previously 
hypothesized in the literature (Hua et al., 2006) and concurs with the negative effect of 
TCl2 on TOI observed in the regression.  
Table 3.7: Results of the Tobit regression model. 
 Coefficient 
estimate 
Standard 
error 
t value p-value Significance 
TI -0.03 0.03 -1.09 0.27392  
T 0.00 0.02 -0.12 0.90492  
pH 1.77 0.88 2.00 0.04517 * 
TCl2 -0.65 0.26 -2.51 0.01207 * 
DOC 2.60 0.57 4.56 0.00001 *** 
NH3-N 0.65 2.24 0.29 0.77229  
SUVA 1.02 0.34 2.99 0.00281 ** 
Chloride 0.00 0.00 0.45 0.65038  
Intercept -16.71 6.08 -2.75 0.00596 ** 
Significance codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 
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Figure 3.7: Relationships between TOI and the eight chosen predictors. The TOI 
concentration is on a log scale. The horizontal dotted line indicates the MDL. 
 The Tobit regression was refit using only the four significant parameters (DOC, 
SUVA254, TCl2, and pH) to develop a predictive model for TOI (Table 3.8). The 
performance of the model against the observed (measured) values of TOI is presented in 
Figure 3.8. The model generally provides a good fit (R2=0.46, p-value < 0.001). In order 
to calculate this R2, we assigned a value of half the MDL (0.475 µg/L) to the twenty-
eight values that were below the MDL. We acknowledge that there is a high variability in 
the data whereby, for example, an observed value of 20 µg/L corresponds to a predicted 
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value of 2 µg/L. This emphasizes the need to improve the current model to minimize 
such errors in prediction. 
Table 3.8: Results of the final Tobit regression model. 
 Coefficient 
estimate 
Standard 
error 
t value p-value Significance 
pH 2.22 0.75 2.95 0.003177 ** 
TCl2 -0.44 0.20 -2.24 0.024997 * 
DOC 2.06 0.39 5.32 1.05e-07 *** 
SUVA 0.60 0.24 2.51 0.011951 * 
Intercept -18.63 5.36 -3.47 0.000521 *** 
Significance codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 
 
Figure 3.8: Predicted versus observed TOI concentration. The covariates used predict the 
TOI concentration are DOC, SUVA, pH, and TCl2. Note: Both x and y axes are on a log 
scale. The R2 for the final Tobit model is 0.46 and the p-value was less than 0.001. 
 
 Although the Tobit model determined the previous four parameters (DOC, 
SUVA254, pH, and TCl2) as the most significant, this does not definitively rule out the 
influence of other parameters on TOI. For instance, as TI concentrations increase in 
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water, it is more likely that TOI concentrations will increase as well, mainly due to the 
higher availability of iodine to form TOI. In fact, iodinated species such as organic 
iodine, iodate, and iodide are labile and can undergo transformation into one another in 
the environment (Amachi et al., 2005a; Councell et al., 1997; Farrenkopf et al., 1997; 
Gong and Zhang, 2013; Radlinger and Heumann, 2000). Our results showed that TOI 
concentrations did increase with an increase in TI concentrations (Figure 3.6) even 
though the regression coefficient was not significant (p-value > 0.05). The positive 
relationship is expected since an increase in TI is expected to be coupled with an increase 
in all three species (iodide, iodate, and organic iodine). The lack of significance could be 
due to remaining multicollinearity between the covariates that confounds significance 
testing. Also, some high TI values at sites B and C during June of 2014 were not 
accompanied by similarly high TOI values (Appendix, Fig. A.2) which led to a 
weakening in the expected signal. 
 Given that TI can be informative in assessing TOI concentration in the water, it is 
worthwhile to examine variations of TI in the water. One aspect of interest is how TI 
varies with other halogens, particularly TBr, due to their similar chemical behavior. Upon 
pooling of all the results, the relationship between the TI and TBr shows that an increase 
in TI is accompanied by a similar increase in TBr (R2=0.45) (Fig. 3.9). This would 
suggest that the heavier halogens vary together and could cause joint variations in 
iodinated and brominated DBPs that are of concern to regulators and utility managers. 
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Figure 3.9: Relationship between TI and TBr. Note: Both x and y axes are on a log scale. 
The R2 for the linear regression between these two (log-transformed) parameters was 
0.45. 
3.4. Implications for water treatment 
 
 The work presented here characterizes TOI and TI in three drinking water 
treatment trains in the Northeast US. We have established the order of magnitude of both 
species over a period of 15 months as well as the differences in the raw water and several 
points in the distribution system. We observed a clear increase in TI during the spring and 
summer months compared to the fall and winter months. Despite the absence of a clear 
seasonal pattern for TOI, there was substantial inter-monthly variability where TOI 
values cluster high or low for months at a time. The TOI concentrations exhibited peak 
values between the late summer and early winter. The results showed that TOI was 
present in the raw water and that there was no change in TOI concentration upon 
treatment, suggesting that the TOI components may have shifted between the raw and 
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treated waters. Although the concentration of TOI and TI did not significantly change 
between raw and treated water, the ratio of TOI to TI was somewhat lower in the treated 
raw water than in the raw water, potentially due to removal of NOM during the treatment 
process.  
 The results of our multivariate regression showed that TOI was correlated with 
DOC, SUVA254, TCl2, and pH to varying degrees. TOI increased with an increase in 
DOC and pH and a decrease in SUVA254 and TCl2. A predictive model that used these 
four parameters was fit for TOI occurrence in water and was able to explain 
approximately 46% of the variance of TOI concentrations in the treated waters. This is 
highly valuable since it will allow the estimation of TOI to a certain degree of certainty in 
relation to commonly measured parameters in a water sample. We also observed a 
positive correlation between TOI and TI as well as between TI and TBr. This indicates 
that the iodine and bromine content could give a broad idea of the expected TOI 
concentration in a water sample. 
 The advantages of using a TOI as a surrogate measure is that it can accurately 
quantify the amount of iodinated organic compounds in a water sample. The drawbacks, 
on the other hand, resemble the drawbacks of using TOX as a surrogate measure. 
Namely, the surrogate TOI does not provide an accurate identification of the contents of 
the water since it does not break down TOI into its specific species. A deeper 
understanding of TOI and the way it varies with the other constituents in a water sample 
is required to mitigate this drawback. This can ultimately lead to improved management 
of the water quality without depending on expensive and complicated analytical 
techniques and equipment. 
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CHAPTER 4 
 
COMPARATIVE CYTOTOXICITY OF SIX IODINATED DISINFECTION BY-
PRODUCTS ON HEALTHY HUMAN EPITHELIAL COLON CELLS 
 
4.1 Introduction  
 Chlorination of drinking water is considered one of the most important public 
health developments of the twentieth century, having decreased water-borne diseases in 
the United States (CDC, 1999). Microorganisms are effectively inactivated in drinking 
water through the use of strong oxidants such as chlorine, chlorine dioxide, and 
chloramines. Non-specific oxidation by these additives to drinking water also oxidize 
natural organic matter (NOM) and bromide/iodide that are naturally present in source 
waters, and further yield halogenated disinfection by-products (DBPs). Exposure to DBPs 
through chlorinated drinking water is a major public health concern given the increased 
risk of bladder, colon, and rectum cancers (Costet et al., 2011; Villanueva et al., 2004; 
Bove et al., 2007; Villanueva et al., 2007; King and Marrett, 1996; Koivusalo et al., 1997; 
Morris et al., 1992; McGeehin et al., 1993; King et al., 2000; Rahman et al., 2010; Bull et 
al. 1995; Cantor et al., 2010).  
 Within the context of water quality, the ultimate goal of public health agencies is 
to ensure that communities are provided with safe drinking water. To increase public 
protection and limit their exposure to DBPs, Stage 1 and Stage 2 Disinfectant and 
Disinfection Byproduct Rules were imposed by the US Environmental Protection Agency 
(USEPA) leading to the regulation of 11 DBPs (EPA, 1998, 2003). Following the 
introduction of the Stage 2 Disinfectant and Disinfection Byproduct Rule, many water 
utilities in the US shifted from the use of free chlorine to the use of chloramine as a final 
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disinfectant in an effort to decrease the formation of regulated DBPs (Seidel et al., 2005; 
USEPA, 2012; Krasner et al., 1989; Zhang et al., 2000). One of the major drawbacks of 
the use of chloramine as a final disinfectant is that monochloramine, the primary active 
disinfectant produced during chloramination, reacts slowly with hypoiodous acid (HOI) 
and this favors a slow reaction between HOI with NOM to form iodinated disinfection 
by-products (I-DBPs) (Bichsel and von Gunten, 1999, 2000). Table 1 shows the twenty 
compounds that are currently identified as I-DBPs in chlorinated and chloraminated 
drinking waters. Of those twenty compounds, fifteen have been detected in chlorinated 
and chloraminated waters (Bichsel and von Gunten, 1999; Brass et al., 1977; Cancho et 
al., 2000; Chu et al., 2012; Glaze et al., 1975; Jeong et al., 2015; Krasner et al., 2006; 
Plewa et al., 2004a; Plewa et al., 2008; Richardson, 2003; Weinberg et al., 2002). In 
simulated chloraminated drinking water, a few hundred I-DBPs were identified (Ding and 
Zhang, 2009; Wang et al., 2016). About half of the I-DBPs reported by Wang et al. 
(2016) had aromatic structure, which had been shown to be substantially more toxic than 
aliphatic I-DBPs (Pan et al., 2016a). Furthermore, I-DBPs are of particular concern 
because of the twenty compounds that have been identified in drinking water, all but one 
has been implicated with enhanced cyto- and genotoxicity compared to their brominated 
and chlorinated analogues (Cemeli et al., 2006; Hunter et al., 1996; Jeong et al., 2015; 
Plewa et al., 2004a; Plewa et al., 2004b; Plewa et al., 2010; Plewa and Wagner, 2009; 
Richardson et al., 2007; Richardson et al., 2008). Although the scope of this study is 
cytotoxicity, genotoxicity, or the ability of a chemical to induce DNA mutations, is 
another measure that is used to assess the toxicity of a chemical. Researchers evaluated 
both cytotoxicity and genotoxicity and concluded that the toxicity ranking of I-DBPs 
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compared with other DBPs is often very similar for the two evaluations (Escobar-Hoyes 
et al., 2013; Pals et al., 2013; Plewa et al., 2004b; Plewa et al., 2008; Plewa et al., 2010). 
They also concluded that the genotoxicity of haloamides, halonitromethanes, and 
haloaldehydes is highly correlated with cytotoxicity (Plewa and Wagner, 2009; Plewa et 
al., 2008; Plewa et al., 2010; Zhang et al., 2010). Therefore, the results of cytotoxicity 
analysis can extend beyond its traditional meaning to be informative as a toxicity 
parameter. 
 Published studies of I-DBPs have primarily evaluated toxicity using Chinese 
Hamster Ovary (CHO) AS52 cell models. Given that the toxicological response of a 
chemical will vary between species due to natural heterogeneity, the response in CHO 
cells cannot necessarily be extended to humans. Therefore, the need to study human cell 
lines that can be directly extended to the epidemiological evidence such as colon and 
bladder in the general population is crucial. Across the twenty I-DBPs of interest, only 
iodoacetic acid has been the subject of cytotoxicity evaluation in human cell lines (Table 
4.1), of which only two used healthy human cells (Attene-Ramos et al., 2010; Escobar-
Hoyes et al., 2013). Given that I-DBPs in drinking water are of public health concern, it 
is important to further assess the toxicity of other I-DBPs. In this study, we chose to 
evaluate the cytotoxicity of I-DBPs on a non-transformed human colon cell line. Since 
previous CHO studies have demonstrated that haloamides, a group of nitrogenous-DBPs, 
exhibit higher toxicity compared to haloacids, a group of non-nitrogenous DBPs (Krasner 
et al., 2006; Plewa et al., 2008; Plewa and Wagner, 2009), we chose a panel of six 
iodoacids and iodoamides to allow for relative comparisons between the carbonaceous 
and nitrogenous groups and between the different cell lines. 
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Table 4.1: Occurrence of I-DBPs in treated water, the cytotoxicity models used, and 
information inferred from cytotoxicity assays  
Group/Compound Occurrence 
in drinking 
water* 
Model Lowest 
cytotoxic 
concentrati
on (µM) 
LC50 Reference 
Iodoacid 
Iodoacetic Acid 
 
+ a, b S. typhimurium 150 ~250 Cemeli et al., 2006 
100 303 Plewa et al., 2004b 
CHO-AS52 cells 0.5 4 Cemeli et al., 2006 
0.5 2.95 Plewa et al., 2004b 
CHO-K1 cells 1.68 5.3 Zhang et al., 2010 
TK6 cells 35 80 Hilliard et al., 1998** 
FHs cells 22 NA Attene-Ramos et al., 
2010 
Caco-2 cells NA 34 Procházka et al., 2015 
HepG2 cells, rat 
hepatocytes, and intact 
rats 
2 8 Wang et al., 2014 
NIH3T3 cells 2.5 2.7 Wei et al., 2013 
Primary human 
lymphocytes 
NA NA Escobar-Hoyes et al., 
2013 
Diiodoacetic acid - CHO-AS52 cells 100 332 Richardson et al., 2008 
Bromoiodoacetic acid +  a, b CHO-AS52 cells 250 897 Richardson et al., 2008 
(Z)-3-bromo-3-
iodopropenoic acid 
+  a, b CHO-AS52 cells 75 208 Richardson et al., 2008 
(E)-3-bromo-3-
iodopropenoic acid 
+  a, b CHO-AS52 cells 25 145 Richardson et al., 2008 
(E)-3-bromo-2-
iodopropenoic acid 
- CHO-AS52 cells 17.5 436 Richardson et al., 2008 
(E)-2-iodo-3-
methylbutenedioic acid 
+  a, b CHO-AS52 cells 700 944 Richardson et al., 2008 
Iodomethane 
Dibromoiodomethane + c CHO-AS52 cells 1500 1900 Richardson et al., 2008 
Dichloroiodomethane + c CHO-AS52 cells 2000 4130 Richardson et al., 2008 
Bromochloroiodomethan
e 
+ c CHO-AS52 cells 2200 2400 Richardson et al., 2008 
Bromodiiodomethane + c CHO-AS52 cells 1500 NA Richardson et al., 2008 
Chlorodiiodomethane + c CHO-AS52 cells 1000 2410 Richardson et al., 2008 
Iodoform + c CHO-AS52 cells 10 66 Richardson et al., 2008 
NIH3T3 cells 55 83.4 Wei et al., 2013 
Iodonitrile 
Iodoacetonitrile - CHO-AS52 cells 0.1 3.3 Muellner et al., 2007 
Iodoamide 
Iodoacetamide - CHO-AS52 cells 0.5 1.42 Plewa et al., 2008 
LLC-PK1 10 NA Chen and Stevens, 1991 
Diiodoacetamide - CHO-AS52 cells 0.025 0.678 Plewa et al., 2008 
Bromoiodoacetamide + d,e CHO-AS52 cells 2 3.81 Plewa et al., 2008 
Chloroiodoacetamide + e CHO-AS52 cells 2 5.97 Plewa et al., 2008 
Iodoaldehyde 
Iodobutanal + a,c NA NA NA NA NA 
Iodoacetaldehyde + f NA NA NA NA NA 
*: indicates positive occurrence (+) and negative occurrence (-); a: Krasner et al., 2006; b: Plewa et al., 2004b; 
c:Weinberg et al., 2002; d: Plewa et al., 2008; e: Chu et al., 2012; f: Jeong et al., 2015. ** indicates that sodium 
iodoacetate was used 
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4.2. Materials and Methods 
4.2.1. Reagents and chemicals 
 Dulbecco’s Phosphate Buffer Saline (D-PBS; 30-2200TM stored at 4 °C), Eagle’s 
Minimum Essential Medium (EMEM; 30-2003TM stored at 4 °C), Penicillin-
Streptomycin Solution (30-2300TM stored at -20 °C), dimethylsulfoxide (DMSO, 4-XTM 
stored at 4 °C), Trypsin-EDTA Solution (1X, 30-2101TM stored at -20 °C), and fetal 
bovine serum (FBS) (30-2020 TM stored at -20 °C) were purchased from American Type 
Culture Collection (ATCC). PrestoBlue® Cell Viability Reagent was obtained from 
ThermoFisher Scientific and stored at 4 °C. Diiodoacetic acid (DIAA, >90%), 
bromoiodoacetic acid (BIAA, >85%), bromoiodoacetamide (BIAcAm, >85%), and 
chloroiodoacetamide (CIAcAm,>99%) were purchased from CanSyn Chemical 
Corporation (Toronto, Canada). Iodoacetamide (IAcAm, >99%) and iodoacetic acid 
(IAA, >98%) were purchased from Sigma-Aldrich. Triton® X-100 (Molecular Biology 
Grade) was obtained from Promega. 
4.2.2. Preparation of solutions 
 Three iodoacids and three iodoamides were prepared to be tested for cytotoxicity 
(Table 4.1). IAA stock solution was prepared by dissolving IAA in EMEM solution 
containing 10% FBS and 1% Penicillin-Streptomycin. For the other five compounds, 
stock solutions were prepared by dissolving each compound in EMEM containing 10% 
FBS, 1% Penicillin-Streptomycin, and 0.1% DMSO. The prepared EMEM solutions 
containing each of the six I-DBPs had a pH between 7 and 7.5 and were used within 4 
weeks. The I-DBPs were assumed to be stable within that range of pH and timeline. 
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Preliminary tests were conducted for each compound to determine the range of 
concentrations to be used for cytotoxicity analysis. Serial dilutions in the appropriate 
media were used to make a total of 6 concentrations for each compound to be analyzed 
for cytotoxicity (Table 4.1). All reported concentrations are in µg/L as I. All solutions 
were stored at 4 °C and used within four weeks. The cells were cultured in EMEM 
containing 10% FBS and 1% Penicillin-Streptomycin (EMEM-C). 
Table 4.2: Summary of the concentration ranges for each of the six I-DBPs 
Compound Molecular 
structure 
Abbreviation Chemical 
formula 
Molecular weight 
(g/mol) 
Iodoacetic acid 
 
IAA C2H3IO2 185.95 
Diiodoacetic acid 
 
DIAA C2H2I2O2 311.84 
Bromoiodoacetic 
acid 
  
BIAA C2H2BrIO2 264.84 
Iodoacetamide 
 
IAcAm C2H4INO 184.96 
Chloroiodoacetamide 
 
CIAcAm C2H3ClINO 219.41 
Bromoiodoacetamide 
 
BIAcAm C2H3BrINO 263.86 
4.2.3. Cell culture 
 Immortalized (non-neoplastic) normal human colon epithelial cells, CCD 841 
CoN (CRL-1790), were obtained from ATCC at passage 13 and were used in all 
experiments between passage 15 and 17. The CCD 841 CoN cells were isolated from a 
21-week gestation fetus that did not show any abnormalities (Thompson et al., 1985). The 
Iodoacetic)Acid Bromoiodoacetic)Acid Diiodoacetic Acid
Iodoacetamide Bromoiodoacetamide Chloroiodoacetamide
Iodoacetic)Acid Bromoiodoacetic)Acid Diiodoacetic Acid
Iodoacetamide Bromoiodoacetamide Chloroiodoacetamide
Iodoacetic)Acid Bromoiodoacetic)Acid Diiodoacetic Acid
Iodoacetamide Bromoiodoacetamide Chloroiodoacetamide
Iodoacetic)Acid Bromoiodoacetic)Acid Diiodoacetic Acid
Iodoacetamide Bromoiodoacetamide Chloroiodoacetamide
Iodoacetic)Acid Bromoiodoacetic)Acid Diiodoacetic Acid
Iodoacetamide Bromoiodoacetamide Chloroiodoacetamide
Iodoacetic)Acid Bromoiodoacetic)Acid Diiodoacetic Acid
Iodoacetamide Bromoiodoacetamide Chloroiodoacetamide
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cells were cultured and maintained in T75 tissue culture flasks with EMEM-C containing 
10% non-heat inactivated FBS and 1% Penicillin-Streptomycin Solution at 37 °C in a 
humidified 5% CO2 incubator. Cells were maintained until 80% confluence before 
subsequent assays described below. 
4.2.4. Human cell cytotoxicity assay 
 CCD 841 CoN cells were seeded (12,500 cells per well) in clear, sterile, 96-well 
microplates with EMEM-C media and cultured at 37 °C in a humidified 5% CO2 
incubator. Upon reaching 80% confluence, the media was replaced with fresh media 
containing different concentrations of the six compounds (exposure media), EMEM-C 
(positive control for IAA), or EMEM-C with 0.1% DMSO (positive control for five other 
compounds). The plates were then incubated for 12 hours at 37 °C in the humidified 5% 
CO2 incubator. At hour 11, Triton® X-100 (1 µL) was added to the positive controls and 
incubated for one hour. Following the exposure period, cells were washed with D-PBS. 
EMEM-C (90 µL) and PrestoBlue (10 µL) were added to each well and incubated for 1 
hour at 37 °C in the humidified 5% CO2 incubator. A SpectraMax® MiniMax™ Imaging 
Cytometer (Molecular Devices) was used to measure the fluorescence at 535 nm for 
excitation and 615 nm for emission at 52 points per well. For each compound, 2 to 5 
biological replicates were tested at each concentration. Exposures were repeated on 3 or 4 
separate days (experimental replicates), yielding a total of 9 to 15 replicates per 
concentration per compound. Cell viability was evaluated as the number of viable cells 
while cell cytotoxicity was evaluated as the reduction in the number of viable cells 
compared to the positive control. 
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4.2.5. Data analysis 
 Cytotoxicity data was normalized to the averaged percent of the corresponding 
negative controls from individual experiments. The average mean viability values 
obtained from the biological and experimental replicates from all the experiments were 
used to construct a cell viability concentration-response curve. The data from each 
compound were used to generate Four-Parameter Logistic nonlinear regression functions 
using the “log(inhibitor) vs. response” equation (Eq. 4.1).  
𝑌 = 𝐵𝑜𝑡𝑡𝑜𝑚 + 𝑇𝑜𝑝 − 𝐵𝑜𝑡𝑡𝑜𝑚 /(1 + 10(E9Dyz{|0})×~\::I:9LM))   Eq. 4.1 
where Y is the percent of cells that are viable, X is the tested concentration, and HillSlope 
is the slope of the sigmoidal curve. The Top and Bottom values were constrained to 100 
(all cells are viable) and 0 (all cells are not viable), respectively. 
 To fit the curve for each compound, the parameters were adjusted to minimize the 
mean square error between the fitted values and observations. The root mean squared 
error was then calculated for each of the fitted curves to reflect every compound 
according to Eq. 4.2. 
𝑅< = 1 − IIII = 1 − (.0,)XT (.0,)XT        Eq. 4.2 
where RSS and TSS stand for residual sum of squares and total sum of squares, 
respectively, n is the number of tested concentrations, 𝑗 is the number of data points from 
1 to n, 𝑖 is the number of compounds, 𝑦, 𝑦, and 𝑦 are the observed, estimated, and 
average viability across the tested concentrations, respectively. 
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 The optimized curves were used to calculate the LC50 values, or the lowest 
concentration at which 50% reduction in cell density is observed as compared to control 
cells. For each LC50 value, a mean cytotoxicity index value was calculated as  1000 𝐿𝐶qas previously described by Jeong et al. (2015) such that a larger value 
corresponds to higher cytotoxicity. Both LC50 and the cytotoxicity index can be used to 
rank the cytotoxicity of the six I-DBPs for this particular cell line. Another measure of 
interest is the lowest cytotoxic concentration, which was determined as the lowest 
concentration that induced a significant reduction in cell density as compared to the 
negative control. The significance was tested using a one-way analysis of variance 
(ANOVA) and a Tukey’s post-hoc test (p-value < 0.05). All data were analyzed using the 
programming language R. 
4.3. Results and discussion 
 An immortalized normal epithelial-like colon cell (CCD 841 CoN) line was 
selected given the positive association reported by epidemiological studies between 
exposure to chlorinated water and increased risk of colon cancer. The CCD 841CoN cells 
were exposed to three iodoacids (IAA, BIAA, and DIAA) and three iodoamides (IAcAm, 
BIAcAm, and CIAcAm) at varying concentrations (Table 4.2) and were analyzed for 
acute cytotoxicity. 
4.3.1. CCD 841 CoN cytoxicity 
 Figure 4.1 presents a dose-response curve for the six DBPs. The viability of CCD 
841 CoN cells was found to decrease in a concentration-dependent manner within the 
tested range of concentrations for the six compounds. Cytotoxicity was evaluated using 
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two parameters: lowest cytotoxic concentration at which there was a statistically 
significant decrease in viable cells compared to the negative control and LC50 (Table 4.3). 
The lowest concentration that was found to induce to a cytotoxic response compared to 
the controls ranged was 8 µM for IAA, 25 µM for IAcAm, 50 µM for BIAcAm, 100 µM 
for both CIAcAM and DIAA, and 1000 µM for BIAA (p-values < 0.05). The LC50 values 
ranged from 8.6 µM for IAA to about 1 mM for DIAA and BIAA. In CCD 841 CoN 
cells, the rank order for cytotoxicity of the six I-DBP compounds based on their LC50 
values was as follows: IAA > IAcAm > BIAcAm > CIAcAm > DIAA ≈ BIAA.  
 
Figure 4.1:  Concentration-response curves of the six I-DBPs on CCD 841 CoN cells. 
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 Table 4.3: Summary of the CCD 841 CoN cell cytotoxicity of the I-DBPs 
I-DBP Tested 
Concentration 
range (µM) 
Lowest cytotoxic 
concentration a 
(µM) 
ANOVA 
p-value 
b 
LC50c 
(µM) 
R2 d Toxic 
rank 
order 
IAA 0.1 - 50 8 0 8.6 0.83 1 
IAcAm 5 - 2000 25 0.0003 39.1 0.76 2 
BIAcAm 25 - 2000 50 0.0008 136.3 0.52 3 
CIAcAm 50 - 5000 100 0.0171 369.0 0.69 4 
DIAA 0.1 - 4000 100 0.0017 954.7 0.51 5 
BIAA 10 - 5000 1000 0.0269 982.2 0.81 6 
aThe lowest cytotoxic concentrations at which a chemical induced a significant cytotoxicity as compared to 
the negative control determined by ANOVA test. 
bThe results of the ANOVA for the lowest cytotoxic concentration 
cThe concentration at which the cell viability was reduced by 50% as compared to the negative control 
determined by the non-linear Four-Parameter Logistic nonlinear regression functions. 
dThe root mean squared error for the non-linear curve fitting 
 A cytotoxicity index value, calculated from LC50, was evaluated as another 
strategy to rank the tested compounds with a higher number corresponding to higher 
cytotoxicity. Figure 4.2 shows the six I-DBPs ranked on the basis of their cytotoxicity 
index value. Of the six iodinated compounds (IAA, BIAA, DIAA, IAcAm, BIAcAm, and 
CIAcAm), IAA exhibited the highest cytotoxicity to CCD 841 CoN cells. This finding is 
in line with published literature which reports enhanced cytotoxicity for IAA compared 
with other haloacetic acids in CHO-AS52 cells (Richardson et al., 2008). The increased 
cytotoxicity of IAA has been attributed to the length of the carbon-halogen bond and the 
number of halogens per atom. As the size of the halogen increases, the dissociation 
energy declines making iodine an excellent leaving group compared to the other 
halogens; this consequently leads to higher cytotoxicity (Plewa et al., 2004b). The pattern 
of decreasing toxicity of I>Br>Cl has been observed for all identified I-DBPs except for 
iodoacetaldehyde (Jeong et al., 2015). Enhanced toxic potency is also attributable to 
fewer halogens are per atom (Plewa et al., 2002). However, previous studies showed that 
the haloacids was less cytotoxic than the haloamides in CHO-AS52 cells (Plewa et al., 
2008, Plewa et al., 2010). These results were consistent with the results of the di-
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halogenated but not for the mono-halogenated compounds in this study: IAA was four 
and a half times more cytotoxic than IAcAm in CCD 841 CoN cells. This may indicate 
that human colon cells are more sensitive to IAA than IAcAm. Since haloamides were 
not explored in other cell lines than CHO cells, the significance is unclear.  
 
Figure 4.2: Comparison of the CCD 841 CoN cells cytotoxicity index values 
(𝐿𝐶q/1000) of the tested I-DBPs. The higher the cytotoxicity index value, the more 
cytotoxic the compound. 
 
 The lowest cytotoxic concentration for IAA in CCD 841 CoN cells was 8 µM, 
corresponding to about 1000 µg/L. The maximum IAA concentration in water utilities 
has been reported at 1.7 µg/L in the US (Richardson et al., 2008) and 2.18 µg/L in China 
(Wei et al., 2013). The lowest cytotoxic concentration of BIAA was 1000 µM. This is 10 
times greater than that of DIAA. However, the LC50, and consequently the cytotoxicity 
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index value of DIAA and BIAA was about the same. The cytotoxicity of both dihaloacids 
(DIAA and BIAA) was less than 1% of that of the monohaloacid IAA. This indicates that 
an increase in halogens per atom was associated with a decrease in the toxic potency of 
DBPs as previously observed in CHO-AS52 cells (Plewa et al., 2002). BIAA has been 
found in chloraminated water across water utilities in the United States, however, 
concentrations have not been reported in the literature (Krasner et al., 2006; Plewa et al., 
2004b; Richardson et al., 2008). DIAA has very been detected and quantified in two 
treated samples at very low concentrations (2.2 and 3.3 ng/L) in China (Pan et al., 2016). 
Although the detected concentrations of IAA are many orders of magnitude lower than 
the lowest cytotoxic concentration, the health outcomes associated with long-term 
exposure may influence the long-term health impacts.   
 IAcAm was 3.5 times more cytotoxic than BIAcAm, which in turn was 2.7 times 
more cytotoxic than CIAcAm to CCD 841 CoN cells. A similar trend was also observed 
in CHO-AS52 cells with respect to monohaloamide cytotoxicity, reinforcing the 
relationship between halogen size on dissociation energy and toxicity (Plewa et al., 2002; 
Plewa et al., 2008). BIAcAm has been detected in the sub- to low- µg/L levels in three 
raw water and nine treated waters around the US (Plewa et al., 2008) and in 3 WTPs in 
China (Chu et al., 2012). These reported levels are below the lowest cytotoxic 
concentration of 50 µM (6.3 mg/L) observed in this study. CIAcAm has not been 
detected in water utilities in the US but has been detected in treated samples from three 
urban water treatment plants in China at concentrations ranging from 80 and 210 ng/L 
(Chu et al., 2012). The detected values are orders of magnitude below the lowest 
cytotoxic concentration reported for CIAcAm reported here which was about 12.7 mg/L 
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(100 µM). The DBP, IAcAm has not been detected in either raw or treated water samples 
(Chu et al., 2012; Plewa et al., 2008).  
 It is worth noting that one of the drawbacks of any in vitro cytotoxicity assay to a 
cell line is that the impact of a toxicant cannot be unequivocally extrapolated to the same 
cell line within humans. This is since the direct exposure of a toxicant to a cell line is 
vastly different from human exposure via ingestion or inhalation, for example. Therefore, 
the effects between the two to the toxicant will not be identical.  
4.3.2. Comparative cytotoxicity of CCD 841 CoN cells and other cell lines 
 Differences across cytotoxicity assays, as well as inherent sensitivity across cell 
lines to particular compounds, will affect the overall response of a cell line to a 
compound (Procházka et al., 2015). Although it is not ideal to relate the sensitivity of 
human cells with mouse or hamster cells because of their characteristic and species 
specific differences, a comparison of the toxicity rank of different cell lines to a toxicant 
could potentially offer some useful insight to these cell lines. The only compound that we 
can do such a comparison on across all I-DBPs is IAA since it has received the most 
attention. 
 Figure 4.3 compares the cytotoxicity of IAA using a variety of mammalian cells, 
including CHO (AS52 and K1), mouse (NIH3T3), and human (HepG2 and CCD 841 
CoN) cells. NIH3T3 cells, CHO-AS52 cells, and CHO-K1 cells were exposed to IAA for 
72 hours (Cemeli et al., 2006; Plewa et al., 2004b; Wei et al., 2014; Zhang et al., 2010). 
With regards to human cells, HepG2 cells were exposed over a 24-hour period to IAA 
(Wang et al., 2014) while CCD 841 CoN cells in this study were exposed for 12 hours. 
The results demonstrate comparable cytotoxicity between the human cell models (CCD 
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841 CoN cells from this study and HepG2 liver cells) (Wang et al., 2014). Compared to 
cell lines of mouse and Chinese hamster origin (CHO-AS52, CHO-K1, and NIH3T3), 
CCD 841 CoN cells were 2 to 3 times less sensitive to IAA (Cemeli et al., 2006; Plewa et 
al., 2004b; Wei et al., 2014; Zhang et al., 2014). Since the size of the mammal directly 
influences its metabolic rate due to anatomic, physiologic, and biochemical differences 
(Perlman, 2016; Schmidt-Nielsen, 1984), the difference in sensitivity could be explained 
by differences in size between small animals (e.g., mice and hamsters) and humans. 
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Figure 4.3: Comparison of the LC50 calculated from the cytotoxicity of IAA on different 
mammalian cell lines from the literature (Cemeli et al., 2006; Plewa et al., 2004b; Zhang 
et al., 2010; Wang et al., 2014; Wei et al., 2013) and the present study. The striped bar 
(NIH3T3) indicates a mouse embryo cell line. The grey bars (CHO) indicate Chinese 
hamster cell lines. The white bar (HepG2) indicates a human liver cell line. The black bar 
(CCD 841 CoN) indicates the human colon cell line used in this study. Note: the CCD 
841 CoN cell exposure time was 12 hours compared to 24 hours for the HepG2 cells and 
72 hours for the NIH3T3 cells, CHO-AS52 cells, and CHO-K1 cells. 
 The cytotoxicity of the other five compounds (DIAA, BIAA, IAcAm, BIAcAm, 
and CIAcAm) have previously only been tested using CHO-AS52 cells (Plewa et al., 
2008; Richardson et al., 2008). Figure 4.4 presents a comparison of the LC50 between the 
five compounds testing CCD 841 CoN cells used in the current study and CHO-AS52 
cells from the published literature. The exposure period for CHO-AS52 cells was 72 
hours compared to 12 hours in our study. The exposure concentration ranges were 
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between 1 and 1000 µM for DIAA, 100 and 2500 µM for BIAA, between 0.5 and 2.5 µM 
for IAcAm, between 2 and 10 µM for BIAcAm, and between 2 and 100 µM for CIAcAm 
for CHO-AS52 cells (Plewa et al., 2008; Richardson et al., 2008). The range of 
concentrations evaluated in our study extend beyond those evaluated in CHO-AS52 cells 
(Table 4.2). The three iodoamides were associated with lower LC50 values (39.1 - 369 
µM) compared to the dihaloacids (~1000 µM) indicating that apart from IAA, 
nitrogenous-DBPs were more cytotoxic than carbonaceous-DBPs. The trend across DBPs 
for both cell lines was found to be similar. The results from our study shows that the 
sensitivity of CCD 841 CoN cells to these five compounds was lower than those reported 
in the literature despite the shorter exposure period and higher exposure concentrations 
(Richardson et al., 2008; Plewa et al., 2008. This may indicate a higher resilience of 
human colon cells to these toxicants than CHO cells, leading to the decrease in observed 
sensitivity. 
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Figure 4.4: Comparison of the LC50 between five I-DBPs on CCD 841 CoN cells (this 
study) and CHO-AS52 cells (Richardson et al., 2008; Plewa et al., 2008). 
4.3. Applications to water treatment systems 
 
 The three tested iodoacids (IAA, BIAA, and DIAA) have been identified and/or 
quantified in real (non-simulated or modified) drinking water. In a nationwide DBP 
occurrence study of the US, it was shown that IAA and BIAA formation was most 
prevalent and the highest in plants that use chloramine as a final disinfectant (Richardson 
et al., 2008). This follows previous studies in the literature that show that chloramination 
increases I-DBP formation compared to chlorination (Bichsel and von Gunten, 1999; 
Bichsel and von Gunten, 2000; Krasner et al., 2006). For iodoacids, several other factors 
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play a role in the extent of formation. For example, iodide levels (due to salt water 
intrusion) in the raw water of two rivers in China caused an increase in IAA 
concentration in the finished (chloraminated) water (Wei et al., 2013). The same was also 
observed in the DBP occurrence study of the US (Richardson et al., 2008). Furthermore, 
the occurrence study showed that WTPs that have a short chlorine contact time prior to 
chloramine addition (<1 min), or those where chlorine and ammonia are added 
simultaneously, form higher concentrations of iodoacids (namely, IAA and BIAA). The 
use of a long chlorine contact time (>45 min) would tend to decrease the formation of 
iodoacids, however it may cause an undesirable increase in regulated HAA and THM 
formation that originally motivated the shift from chlorination to chloramination.  
 As a class, iodoamides have been shown to be about 100 times more cytotoxic 
compared to HAAs in CHO cells (Plewa et al., 2008). We showed that apart from IAA, 
the three tested iodoamides were more cytotoxic in CCD 841 CoN cells than the 
haloacids. Of the three tested iodoamides in this study, two (BIAcAm and CIAcAm) have 
been identified and quantified in real chlorinated and chloraminated drinking water. In 
the nationwide occurrence study, BIAcAm was found in the raw and treated water of 
three WTPs as well as in the treated water of nine other WTPs (Plewa et al., 2008). All 
twelve WTPs had a naturally high iodide and bromide content and used chloramine as a 
final disinfectant. Chu et al. (2012) also identified and measured both CIAcAm and 
BIAcAm in 3 WTPs in China either due to chlorination or chloramination. IAcAm was 
the most cytotoxic of the three iodoamides in our study but it has yet to be identified in 
treated waters (Chu et al., 2012; Plewa et al., 2008). Haloacids have been extensively 
studied in the literature since they were first identified as a DBP. Similar efforts need to 
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be put forth for the newly identified nitrogenous I-DBPs to develop strategies for 
controlling their formation. 
 This study suggests that IAA and the three iodoamides (IAcAm, BIAcAm, and 
CIAcAm) should be prioritized given their enhanced cytotoxicity observed in a human 
cell line. Further studies need to be conducted to understand the specific factors that lead 
to their formation in drinking water while also meeting the DBP regulatory standards. It 
would be extremely useful to monitor the concentration of TOI as well as some of the 
identified priority I-DBPs in actual water treatment plants and their distribution system to 
assess how they vary together. This could give a higher utility to the use of TOI as a 
surrogate for I-DBPs. 
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CHAPTER 5 
 
CONCLUSIONS 
  
 TOI is a convenient aggregate measure of I-DBPs in disinfected water. A new 
TOI method was developed that builds on previous methods while overcoming their 
drawbacks. The method entailed adsorbing a highly acidified sample (pH<1) onto two 
granular activated carbon columns, combustion of the two columns to release HI gas that 
gets trapped in a basic (pH~12) water solution. The solution is then analyzed using the 
ICP-MS with a wash solution of TMAH (0.1% v/v.) This method effectively recovered a 
wide range of iodinated organics. Given the method’s low detection limit, we were also 
able to successfully measure TOI in raw and treated water at very low concentrations. 
 Upon developing this TOI method, we were able to investigate the presence of 
ambient TOI in raw and treated waters. We established the order of magnitude and the 
patterns of variation of TOI, as well as the contribution of TOI to TI in multiple raw 
water locations, water treatment sites, and distribution systems. By doing so, we created a 
novel data set of TOI. One of the original objectives of this work was to develop 
predictive models for TOI in treated water, as measuring TOI requires advanced 
analytical instrumentation. Having a comprehensive data set enabled us to do this by 
exploring the correlations between TOI and routinely measured parameters in treated 
water. DOC, SUVA, TCl2, and pH were all significantly related to TOI concentration to 
varying degrees and explained about half of the variance of TOI concentration. This work 
shows the potential of predicting TOI in treated water based on its physical and chemical 
parameters. 
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 Since most toxicity studies of I-DBPs have been conducted on CHO cells, there 
was a need to study human cell lines that can be directly extended to the epidemiological 
evidence such as colon and bladder cancer in the general population. Therefore, we 
evaluated the cytotoxicity of six I-DBPs (three iodoacids and three iodoamides) on a non-
transformed human colon cell line. Several toxicity parameters enabled us to study the 
response of the human colon cell line to different tested I-DBPs and subsequently rank 
their cytotoxicity. Our study suggests that IAA and the three iodoamides tested here 
should be prioritized with regards to preventing their formation given their enhanced 
cytotoxicity observed in a human cell line. In order for these advances to be useful for 
management of public health, we need to ensure that variations in TOI also reflect 
variations in the I-DBPs that are of greatest health concern. Therefore, future work is 
needed to measure the variations of these I-DBPs in water systems with respect to 
variations in TOI. 
 Future studies are also needed to characterize the toxicity of I-DBPs and to 
develop toxicity libraries among other halogenated DBPs using the human colon cell line. 
This includes expanding the cytotoxicity assessment to include the other haloacids and 
haloamides that were not covered in this study, as well as the I-DBPs from other 
iodinated groups that have been identified in treated waters. In parallel, a comparative 
cytotoxicity assessment with brominated and chlorinated DBPs from those same groups 
should be conducted. This will allow for a creation of a new ranking system of DBP 
toxicity by group and by compound to complement the existing CHO one. Furthermore, 
studies are also needed to evaluate the cellular and molecular mechanisms associated 
with I-DBPs since they are not well understood. A toxicogenomic study is one approach 
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that can be very informative in analyzing changes in gene expression in the CCD 841 
CoN cell line due to exposure to I-DBPs. It would provide insight on the mode of action 
of the toxicants and on the gene expression profiles related to adverse impacts such as 
oxidative stress, inflammation, cancer, and changes in metabolism. The ultimate hope is 
that this cell culture can be used as a prototype of human colon tissue to simulate the 
response of human cells to exposure to I-DBPs. 
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  SYMBOLS AND ABBREVIATIONS 
 𝐼0: iodide 𝐼𝑂20: iodate 𝐼<: elemental iodine 𝑁𝑎𝐼𝑂2 : sodium iodate 
ANOVA: analysis of variance 
ATCC: American Type Culture Collection 
BIAA: bromoiodoacetic acid 
BIAcAm: bromoiodoacetamide 
CCD 841 CoN: Human non-transformed (healthy) epithelial colon cells 
CHO: Chinese Hamster Ovary cells 
CIAcAm: chloroiodoacetamide 
D-PBS: Dulbecco’s Phosphate Buffer Saline 
D/DBP: disinfectant and disinfection byproduct 
DBPs: disinfection by-products 
DIAA: diiodoacetic acid 
DMSO: dimethylsulfoxide 
DOC: dissolved organic carbon 
DS: distribution system 
EMEM-C: Eagle’s Minimum Essential Medium-Complete 
EMEM: Eagle’s Minimum Essential Medium 
GAC: granular activated carbon 
HI: hydrogen iodide 
HNO3: nitric acid 
HOI: hypoiodous acid 
I-DBPs: iodinated disinfection by-products 
I-THMs: iodinated trihalomethanes 
IAA: iodoacetic acid 
IAcAm: iodoacetamide 
IC: Ion Chromatography 
ICM: iodine x-ray contrast media 
ICP-MS: Inductively Coupled Plasma – Mass Spectrometer 
KBr: potassium bromide 
KI: potassium iodide 
MDL: method detection limit 
NaI: sodium iodide 
NH3-N: ammonia-nitrogen 
NO2-N: nitrite-nitrogen 
NO3-N: nitrate-nitrogen 
NOM: natural organic matter 
POE: point of entry 
SUVA: specific UV absorbance 
TBr: total bromine 
TCl2: combined chlorine residual 
TI: total iodine 
  87 
TII: total inorganic iodine 
TMAH: tetramethyl ammonium hydroxide 
TOBr: total organic bromine 
TOC: total organic carbon 
TOCl: total organic chlorine 
TOI: total organic iodine 
TOX: total organic halogen 
WTP: water treatment plant 
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APPENDIX 
SUPPORTING INFORMATION 
 
 
 
 
Figure A.1: Graphical representation of the chosen TOI method 
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Table A.1: Average physical and chemical characteristics of the real water samples over 
the two summer months 
 
Index Type of 
Water 
1pH T 
(°C) 
Conductivity 
(µS/cm) 
TOC 
(mg/L) 
 DOC 
(mg/L) 
Residual 
Chlorine 
(mg/L) 
UV254 
(1/cm) 
SUVA254 
(L.mg-
1m-1) 
A Raw 7.64 27 241 2.78 2.24 NA 0.079 3.53 
A1 Treated 7.26 28 333 1.19 1.18 2.80 0.034 2.85 
A2 Treated 7.21 27 335 1.19 1.10 2.53 0.034 3.09 
A3 Treated 7.31 27 336 1.14 1.08 2.15 0.032 2.96 
B Raw 7.89 26 548 2.98 2.47 NA 0.073 2.94 
B1 Treated 7.20 26 576 1.57 1.46 2.86 0.046 3.16 
B2 Treated 7.15 27 534 1.65 1.55 1.67 0.039 2.49 
B3 Treated 7.18 26 546 1.53 1.55 1.58 0.042 2.69 
C Raw 7.99 27 488 2.61 2.51 NA 0.069 2.75 
C1 Treated 7.32 26 596 1.56 1.49 1.98 0.041 2.76 
C2 Treated 7.23 26 592 1.74 1.65 1.60 0.037 2.24 
C3 Treated 7.31 26 580 1.63 1.60 1.42 0.037 2.32 
1 at the collection point prior to ascorbic acid addition 
Appendix Text - Statistical Analyses 
In the ANOVA, the general term 𝑇Z,[,P\  is used to denote the sum of mean effects for the ith 
observation associated with the levels for Factors 1, 2, and 3, indexed by r, s and t, 
respectively (Eq. A.1).  
𝑇Z,[,P\ = 𝜇 + 𝐹1Z + 𝐹2[ + 𝐹3P + (𝐹1𝐹2)Z[ + (𝐹1𝐹3)ZP + 𝐹2𝐹3 [P + (𝐹1𝐹2𝐹3)Z[P + 𝜀Z,[,P\           Eq. A.1 
Here, 𝜇 is the factor-independent mean of 𝑇; 𝐹1Z, 𝐹2[, and 𝐹3P are the main effect model 
terms; (𝐹1𝐹2)Z[, 𝐹1𝐹3 ZP, and 𝐹2𝐹3 [P are the two-way interaction model terms; (𝐹1𝐹2𝐹3)Z[P is the three-way interaction model term; and 𝜀Z,[,P\  is the noise/error 
component.  
For the eight organic model compounds, the ANOVA was conducted using the 
normalized adjusted recoveries by replacing 𝑇Z,[,P\  with 𝑦Z,[,P\ . The 𝑦Z,[,P\  are pooled 
together in the ANOVA for all 8 model compounds and 2 duplicates in order to increase 
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the statistical power of the test. That is, i=1,…,16 observations are available for each 
treatment after pooling. However, the ANOVA tests are repeated for each compound 
separately to verify the results and explore differences between compounds. 
For the inorganic compounds, the ANOVA was conducted by replacing 𝑇Z,[,P\  with 𝑅𝑗Z,[,P\  
for each of the low and high concentrations, and for both sets of concentrations pooled 
together. 
Finally, for the real water samples, the ANOVA was conducted upon pooling of the raw 
and treated waters by replacing 𝑇Z,[,P\  with the actual concentrations of TOI under 
different factors. This was done after it was determined that there was an insignificant 
difference between the raw and treated water samples. 
Table A.2: The ANOVA results for the standardized adjusted recovery of the eight 
compounds for the three factors 
 
Compound ANOVA p-value Factor 1 Factor 2 Factor 3 
IAA 0.007 0.014 2.6e-07 
BIAA 0.010 0.041 0.040 
TIAA 0.906 0.722 1.7e-06 
2-hydroxy-3-iodo-5-
nitropyridine 0.853 0.777 0.460 
3-iodo-4-methylbenzoic acid 0.130 0.644 0.008 
Iopromide 0.219 0.787 0.032 
Diatrizoic acid 0.676 0.588 2.2e-07 
Iopamidol 0.004 0.081 0.679 
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Table A.3: The TOI concentration ranges of the field samples (both raw and treated 
water) without distinction between the variation in the choice of Factors. 
 
Index Type of 
Water 
Concentration Range (µg/L as 
I) 
July August 
A Raw b.d.l. - 6.42 2.34 - 4.36 
A1 Treated b.d.l. - 7.89 2.33 - 5.28 
A2 Treated b.d.l. - 5.72 0.69 - 2.53 
A3 Treated 1.29 - 3.78 1.42 - 3.64 
B Raw 7.31 - 13.55 5.95 - 11.03 
B1 Treated 0.38 - 7.34 5.53 - 6.95 
B2 Treated 3.76 - 7.55 4.14 - 6.79 
B3 Treated 1.73 - 8.02 4.93 - 6.52 
C Raw b.d.l. - 5.53 2.45 - 4.89 
C1 Treated 0.88 - 6.38 4.32 - 7.41 
C2 Treated 2.63 - 7.41 6 - 9.19 
C3 Treated b.d.l. - 7.52 6.01 - 11.91 
*b.d.l. indicates a concentration below the method’s detection limit. 
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Figure A.2: Concentration of TOI and total inorganic iodine (TII; sum of iodide and 
iodate) across the twelve locations and 15 months. * represents TOI values that were 
below the MDL of 0.95, even if a value was measured 
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Table A.4: Median physical and chemical characteristics of the field samples over the 15 
months. 
 
Sample Type T 
range 
(deg 
C) 
pH 
range 
Conductivity 
range 
(µS/cm) 
TOC 
range 
(mg/L) 
DOC 
range 
(mg/L 
Residual 
chlorine 
range 
(mg/L) 
UV254 
range 
(1/cm) 
SUVA 
range 
(L/(mg*m) 
A-Raw Raw 2 - 28 7.15 - 
7.94 
203 - 290 1.93 - 
3.18 
1.35 - 
2.78 
NA 0.065 
- 
0.113 
3.04 - 5.33 
A-POE Treated 2 - 28 7.01 - 
7.32 
272 - 427 0.95 - 
1.34 
0.92 - 
1.76 
2.15 - 
2.8 
0.026 
- 0.04 
2.05 - 4.17 
A-DS1 Treated 3 - 27 7.02 - 
7.3 
285 - 362 1.1 - 
1.23 
0.95 - 
1.17 
2.1 - 2.8 0.027 
- 
0.036 
1.9 - 3.82 
A-DS2 Treated 5 - 27 7.04 - 
7.33 
294 - 371 0.98 - 
1.35 
0.94 - 
1.26 
1.5 - 2.5 0.024 
- 
0.036 
2.44 - 3.26 
B-Raw Raw 2 - 26 7.78 - 
8.78 
290 - 631 1.57 - 
3.21 
1.15 - 
2.93 
NA 0.044 
- 
0.107 
2.46 - 4.38 
B-POE Treated 2 - 26 7.12 - 
7.32 
433 - 698 1.02 - 
1.78 
1.02 - 
1.71 
1.9 - 3.2 0.03 - 
0.048 
2.34 - 3.42 
B-DS1 Treated 5 - 27 6.99 - 
7.4 
402 - 688 1.06 - 
1.7 
0.91 - 
1.6 
0.95 - 
2.22 
0.027 
- 
0.041 
2.09 - 3.48 
B-DS2 Treated 3 - 26 6.93 - 
7.28 
368 - 640 1.1 - 
1.68 
0.95 - 
1.69 
1 - 2.21 0.027 
- 
0.044 
2.35 - 3.1 
C-Raw Raw 2 - 27 7.23 - 
9.29 
414 - 535 1.5 - 
3.85 
1.11 - 
3.49 
NA 0.046 
- 
0.162 
2.39 - 4.64 
C-POE Treated 1 - 27 7.07 - 
7.45 
486 - 637 0.98 - 
1.86 
0.92 - 
1.72 
1.8 - 
2.59 
0.025 
- 
0.044 
1.86 - 3.24 
C-DS1 Treated 4 - 27 6.96 - 
7.45 
429 - 634 0.89 - 
1.95 
0.86 - 
1.91 
1.3 - 2.2 0.025 
- 
0.041 
2.09 - 3.49 
C-DS2 Treated 5 - 26 7.02 - 
7.42 
438 - 616 1.2 - 
2.29 
0.98 - 
1.88 
1.2 - 
2.29 
0.025 
- 
0.041 
1.85 - 3.45 
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